Felty's syndrome: Felty syndrome (FS), also known as ''super rheumatoid'' disease, is a severe form of rheumatoid arthritis (RA), characterized by a triad of RA, splenomegaly and neutropenia, resulting in susceptibility to bacterial infections.
Seropositive rheumatoid arthritis, strict definition
DOID EFO Endpoint Browser PheWeb
RHEUMA_SEROPOS_STRICT
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
11802 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
6333 |
4. Check minimum number of eventsNone |
6333 |
5. Include endpointsNone |
6333 |
6. Filter based on genotype QC (FinnGen only) |
6333 |
Control definitions (FinnGen only)
- Control conditions
- not RHEUMA_SEROPOS_OTH_ICD10
Extra metadata
- First used in FinnGen datafreeze
- DF3
Similar endpoints
↥List of similar endpoints to
Seropositive rheumatoid arthritis, strict definition
based on the number of shared cases.
Similar with more cases:
- Other/unspecified seropositive rheumatoid arthritis (ICD-10)
- Other/unspecified seropositive rheumatoid arthritis
- Seropositive rheumatoid arthritis, wide
- Seropositive rheumatoid arthritis
- Rheumatoid arthritis
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 31325 | 21200 | 9976 |
| Only index persons | 29603 | 20324 | 9279 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.50 | 0.61 | 0.28 |
| Only index persons | 0.62 | 0.75 | 0.35 |
| Median age at first event (years) | |||
| Whole population | 59.60 | 59.01 | 60.86 |
| Only index persons | 59.06 | 58.50 | 60.29 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 6333 | 4420 | 1913 |
| Unadjusted period prevalence (%) | 1.31 | 1.51 | 0.84 |
| Median age at first event (years) | 56.90 | 55.20 | 60.84 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 5569
- Matched controls
- 55691
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
16.9
323.0
610
402
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
101.8
323.0
1833
267
L04AB01
ATC
etanercept; parenteral
81.8
323.0
872
126
L04AB04
ATC
adalimumab; parenteral
37.3
323.0
754
233
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
+∞
323.0
5569
2268
L04AA13
ATC
leflunomide; oral
109.4
323.0
1609
206
M01CB01
ATC
sodium aurothiomalate; parenteral
156.2
323.0
803
60
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
220.8
323.0
4888
1750
L88
ICPC
Rheumatoid/seropositive arthritis
59.1
323.0
1941
499
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
9.3
323.0
1550
2210
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
41.4
323.0
2763
1293
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
43.2
323.0
2926
1389
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
47.6
323.0
619
146
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
42.0
323.0
474
123
P01BA02
ATC
hydroxychloroquine; oral
198.8
323.0
4744
1562
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
71.1
323.0
1562
304
NH3EA
NOMESCO Finland
Feet X-ray examination with load
17.5
323.0
561
355
H02AB06
ATC
prednisolone; systemic
12.2
323.0
4793
18726
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
18.6
323.0
674
409
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
93.7
323.0
1687
257
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
13.1
323.0
1923
2158
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
1772.4
323.0
1883
16
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4503599627370496.0
323.0
5444
31
A07EC01
ATC
sulfasalazine; oral, rectal
82.3
323.0
3849
1473
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.7
323.0
3559
13195
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
69.8
323.0
2017
449
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
18.6
323.0
609
366
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
291.6
323.0
645
25
M13.9
ICD-10 Finland
Arthritis, unspecified
6.1
320.4
957
1818
L04AA24
ATC
abatacept; parenteral
265.3
319.8
325
13
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
15.9
307.3
518
357
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
90.6
298.2
332
39
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
291.9
3113
17211
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
9.0
283.2
636
787
H02AB07
ATC
prednisone; oral
3.7
271.8
1398
4578
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
56.1
249.8
298
56
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
19.5
248.1
386
212
L04AA17
ATC
[U] adalimumab; parenteral
359.7
242.4
243
7
M06
ICD-10 Finland
Other rheumatoid arthritis
83.2
239.0
269
34
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
12.8
229.6
423
354
L04AB06
ATC
golimumab; parenteral
39.8
228.4
291
77
M01CB03
ATC
auranofin; oral
53.0
222.5
268
53
L04AA01
ATC
[U] ciclosporin; systemic
17.2
218.5
355
219
TNG10
NOMESCO Finland
Puncture of knee
21.6
211.4
317
155
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
9.9
209.1
441
481
L04AA11
ATC
[U] etanercept; parenteral
127.8
205.9
221
18
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
44.3
191.1
238
56
L04AC07
ATC
tocilizumab; parenteral
204.1
190.4
197
10
R4120
NOMESCO Finland
Occupational therapy
4.8
188.4
693
1614
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
14.3
187.8
329
244
3006
Kela drug reimbursment
Baricitinib
329.1
187.5
189
6
L04AB05
ATC
certolizumab pegol; parenteral
57.3
180.9
215
39
293
Kela drug reimbursment
Baricitinib
316.1
180.2
182
6
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.3
179.5
731
1880
NDG30
NOMESCO Finland
Fusion of wrist, total
73.1
173.0
198
28
L04AA37
ATC
baricitinib; oral
259.6
172.6
176
7
L04AX01
ATC
azathioprine; systemic
5.8
167.9
508
943
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
6.1
166.0
484
857
291
Kela drug reimbursment
Tofacitinib
99.0
165.2
182
19
ZX140
NOMESCO Finland
Intra articular
22.9
164.8
242
110
WZA10
NOMESCO Finland
Long statement of health and health related matters
13.7
157.9
281
215
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
22.4
156.8
232
108
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
25.2
156.3
223
92
M25.5
ICD-10 Finland
Pain in joint
2.3
151.2
1966
10804
NDL52
NOMESCO Finland
Tenosynovectomy of hand
27.9
148.0
205
76
L04AA29
ATC
tofacitinib; oral
75.4
147.4
168
23
XX9XE
NOMESCO Finland
Other ultrasound examination
17.5
145.5
234
139
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
9.6
144.2
307
337
ZX120
NOMESCO Finland
Intravenous
3.3
142.8
816
2759
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
22.7
132.6
195
89
L01CB
ATC
Podophyllotoxin derivatives
413.1
122.2
122
*
3005
Kela drug reimbursment
Tofacitinib
75.1
122.0
139
19
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
7.8
120.9
292
394
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
55.2
117.3
140
26
M05BA04
ATC
alendronic acid; oral
3.1
116.5
708
2477
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
47.1
112.4
138
30
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
12.9
111.5
203
163
M12.3
ICD-10 Finland
Palindromic rheumatism
55.8
110.0
131
24
RT272
NOMESCO Finland
NA
40.7
110.0
139
35
M01AH05
ATC
etoricoxib; oral
1.9
103.9
3443
25951
M01AH01
ATC
celecoxib; oral (coxibs)
2.2
102.2
1259
6521
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
12.1
102.0
191
163
1XC02
NOMESCO Finland
NA
18.2
101.9
161
91
A02BC02
ATC
pantoprazole; systemic
1.9
98.3
3768
29539
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
5.8
97.7
290
519
NG1DA
NOMESCO Finland
X-ray of knees
7.3
93.5
235
336
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
4.0
91.4
392
1034
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.5
90.4
817
3609
M01AC06
ATC
meloxicam; systemic, rectal
1.8
88.1
2270
15398
TNC11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in elbow joint
38.1
87.6
112
30
M13.0
ICD-10 Finland
Polyarthritis, unspecified
9.6
85.5
180
193
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.1
85.3
515
1777
L04AC14
ATC
sarilumab; systemic
799.8
80.6
79
*
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
18.9
79.8
124
67
NDF10
NOMESCO Finland
Synovectomy of wrist
82.3
79.2
89
11
NH3AE
NOMESCO Finland
Feet ultrasound examination
38.8
77.8
99
26
L20
ICPC
Joint symptom/complaint NOS
4.0
77.8
328
850
SPAT1202
SPAT
Intra-articular injection
4.1
76.5
313
789
H02AB04
ATC
methylprednisolone; systemic
2.1
75.2
958
4953
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.4
72.2
382
1194
9522
FHL
Synovectomy
113.0
72.0
78
7
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
10.5
71.9
144
141
RK210
NOMESCO Finland
NA
37.0
70.9
91
25
RT310
NOMESCO Finland
NA
68.4
70.4
81
12
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
4.0
69.9
297
774
L04AD01
ATC
ciclosporin; systemic
6.1
69.8
199
338
TNH10
NOMESCO Finland
Joint puncture, ankle joint or foot joint
63.2
69.6
81
13
M05BA07
ATC
risedronic acid; oral
3.9
67.9
294
779
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
66.9
1241
7387
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.8
66.4
451
1673
ND1AE
NOMESCO Finland
Wrist ultrasound examination
21.9
65.8
97
45
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.6
65.8
522
2126
NF1AA
NOMESCO Finland
Hip X-ray examination
2.5
65.7
569
2432
RK220
NOMESCO Finland
NA
19.2
64.9
100
53
7140B
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]
37.8
64.2
82
22
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
4.2
62.3
250
618
NDB78
NOMESCO Finland
Prosthetic replacement of several of finger or metacarpal
133.5
62.0
66
5
R4110
NOMESCO Finland
Physiotherapy
1.7
61.7
1508
9782
D06BB04
ATC
podophyllotoxin; topical
3.3
61.7
327
1021
WX320
NOMESCO Finland
Spinalanesthesy
1.8
61.3
1303
8085
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
6.9
61.2
158
235
M05.0
ICD-10 Finland
Felty syndrome
159.2
60.0
63
*
NDF60
NOMESCO Finland
Operation for osteochondritis of a joint of hand,v
31.2
60.0
80
26
M06.3
ICD-10 Finland
Rheumatoid nodule
94.0
58.9
65
7
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
56.9
2328
17314
RT271
NOMESCO Finland
NA
35.2
56.4
73
21
WX204
NOMESCO Finland
Axillary plexus blockaced
3.8
56.2
248
668
M05.3
ICD-10 Finland
Rheumatoid arthritis with involvement of other organs and systems
89.6
55.9
62
7
298
Kela drug reimbursment
NA
553.5
55.7
55
*
H02AB08
ATC
triamcinolone; systemic
17.2
55.1
88
52
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.2
54.7
583
2752
M01AH02
ATC
rofecoxib; oral
2.0
54.6
819
4472
R4180
NOMESCO Finland
Podiatric therapy
8.0
53.1
124
159
3029
Kela drug reimbursment
Upadacitinib
185.1
53.0
55
*
NHG22
NOMESCO Finland
Fusion of subtalar joint
12.3
52.9
97
80
9503
FHL
Tendon or tendon sheath cleansing surgery (tenosynovectomy)
22.0
51.8
76
35
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
50.5
2149
15985
ZXA00
NOMESCO Finland
Right side
1.6
50.1
1492
10126
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
50.1
1126
7046
9256
FHL
Synovectomy (knee 9311)
92.6
49.9
55
6
M05BX04
ATC
denosumab; parenteral
2.8
49.8
349
1314
M17.5
ICD-10 Finland
Other secondary gonarthrosis
6.2
49.1
137
227
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
4.9
49.0
167
351
S18
ICPC
Laceration/cut
1.5
48.6
2204
16595
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
48.6
2459
18993
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
10.0
48.6
99
101
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
16.0
48.2
79
50
NDB60
NOMESCO Finland
Prosthetic replacement of MCP joint of finger
89.2
47.9
53
6
NHM99
NOMESCO Finland
Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot
9.9
47.3
97
100
L11
ICPC
Wrist symptom/complaint
2.3
46.6
474
2183
NHG82
NOMESCO Finland
Fusion of other tarsal joint
6.8
46.1
119
178
N02AX02
ATC
tramadol; systemic, rectal
1.5
45.4
2225
16971
TQW40
NOMESCO Finland
Remowal of suture of skin
2.3
45.1
443
2004
R1250
NOMESCO Finland
Evaluation of functional capability
4.2
44.9
179
440
M01AE02
ATC
naproxen; oral, rectal
1.5
44.4
3000
24491
RS221
NOMESCO Finland
NA
5.3
44.1
138
264
M01CC01
ATC
penicillamine; oral
52.4
43.6
52
10
WZC30
NOMESCO Finland
Teaching
1.9
43.1
760
4371
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.4
42.5
393
1723
N02BE01
ATC
paracetamol; systemic, rectal
1.6
42.2
4678
42402
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
2.0
41.6
597
3183
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.7
41.5
296
1126
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
41.5
541
2776
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
41.5
1936
14521
WX203
NOMESCO Finland
Infraclavicular plexus blockade
4.0
41.4
172
440
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
30.8
41.4
55
18
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.9
41.2
176
461
TNB10
NOMESCO Finland
Joint puncture, shoulder joint
21.6
40.9
60
28
J01DB01
ATC
cefalexin; oral
1.6
40.9
4356
38856
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
4.8
40.8
140
297
R5120
NOMESCO Finland
Preparation of an aid
3.7
40.8
186
516
NCF10
NOMESCO Finland
Synovectomy of elbow joint, open
53.8
40.5
48
9
M05BA06
ATC
ibandronic acid; systemic
3.9
40.4
171
445
K71
ICPC
Rheumatic fever/heart disease
400.4
40.1
40
*
RT171
NOMESCO Finland
NA
28.7
39.9
54
19
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
6.9
39.9
102
151
M19.2
ICD-10 Finland
Other secondary arthrosis
5.8
39.8
115
200
L04AA44
ATC
upadacitinib; oral
141.0
39.8
42
*
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.8
39.4
771
4578
R2110
NOMESCO Finland
Giving the first information
2.2
38.9
426
2025
NDF68
NOMESCO Finland
Operation for osteochondritis of several joints of hand, open
74.0
38.9
44
6
J99.0*M05.1
ICD-10 Finland
Rheumatoid lung disease
+∞
38.6
37
*
NDG74
NOMESCO Finland
Fusion of first IP joint
19.5
38.2
58
30
M01AX17
ATC
nimesulide; oral
1.6
38.0
1363
9578
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.2
37.7
210
680
A02BC03
ATC
lansoprazole; oral
1.5
37.3
1557
11323
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
2.2
37.1
410
1956
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
6.0
37.0
105
179
M06.4
ICD-10 Finland
Inflammatory polyarthropathy
16.0
36.8
60
38
J01FF01
ATC
clindamycin; systemic
1.5
36.5
1413
10092
9284
FHL
Wrist ossification surgery
80.7
35.8
40
5
ZZH31
NOMESCO Finland
Bone allograft, small pieces
7.3
35.8
87
120
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
35.3
897
5747
M01AX01
ATC
nabumetone; oral
2.5
35.1
291
1203
M01AB55
ATC
diclofenac, combinations; oral
2.1
34.8
421
2087
RJ410
NOMESCO Finland
NA
12.8
34.7
62
49
TGC00
NOMESCO Finland
Bronchial lavation
3.4
34.7
178
543
L17
ICPC
Foot/toe symptom/complaint
1.5
34.6
1313
9312
ZXA05
NOMESCO Finland
Left side
1.5
34.5
1327
9438
NDL66
NOMESCO Finland
Transposition of tendon of wrist or hand, other tendon
13.1
34.5
61
47
RF120
NOMESCO Finland
NA
5.1
34.1
111
223
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.0
34.1
203
689
NHF80
NOMESCO Finland
Operation for debridement of toe joint, open
34.1
34.0
44
13
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
10.4
34.0
67
65
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
5.6
33.9
101
183
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.4
33.9
308
1339
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.7
33.6
248
961
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.1
33.6
406
2011
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.3
33.4
177
554
NCM20
NOMESCO Finland
Excision of synovial ganglion of elbow or forearm
15.0
33.0
55
37
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.0
32.9
201
693
RT231
NOMESCO Finland
NA
90.6
32.7
36
*
P01BA01
ATC
chloroquine; systemic
9.4
32.7
68
73
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
2.4
32.2
284
1214
RK250
NOMESCO Finland
NA
10.1
32.0
64
64
L84
ICD-10 Finland
Corns and callosities
2.9
32.0
206
736
ND2AE
NOMESCO Finland
Hand and fingers ultrasound examination
16.6
31.9
51
31
4AA24
NOMESCO Finland
NA
165.9
31.7
33
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
31.7
388
1933
TNF11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in hip joint
22.7
31.3
45
20
RJ511
NOMESCO Finland
NA
21.1
31.3
46
22
SPAT1229
SPAT
Assessment of need for aid
2.0
31.2
426
2217
L12
ICPC
Hand/finger symptom/complaint
1.7
30.9
729
4558
RS222
NOMESCO Finland
NA
5.0
30.7
101
206
RF410
NOMESCO Finland
NA
4.8
30.6
105
224
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
30.5
533
3036
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
30.5
596
3523
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
4.7
30.2
104
223
NDC40
NOMESCO Finland
Secondary prosthetic replacement in of joint of finger or metacarpal
83.1
29.7
33
*
-1
NOMESCO Finland
NA
1.4
29.7
1584
12011
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
3.5
29.6
141
407
9272
FHL
Metatarsophalangeal joint resection
17.8
29.6
46
26
S97
ICPC
Chronic ulcer skin
2.3
29.5
279
1238
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.5
29.3
239
980
M43.4
ICD-10 Finland
Other recurrent atlantoaxial subluxation
57.0
29.1
34
6
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
28.9
1406
10455
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.1
28.9
356
1778
NDG76
NOMESCO Finland
Fusion of DIP joint
6.1
28.8
79
130
N05.8
ICD-10 Finland
Unspecified nephritic syndrome, other
150.8
28.7
30
*
RF420
NOMESCO Finland
NA
4.2
28.6
110
264
M13.8
ICD-10 Finland
Other specified arthritis
5.6
28.4
84
152
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.7
27.8
199
759
NCB20
NOMESCO Finland
Primary total prosthetic replacement of elbow joint
32.9
27.7
36
11
RS121
NOMESCO Finland
NA
7.6
27.7
65
86
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.2
27.2
281
1299
NG2CA
NOMESCO Finland
X-ray of patella with specialised projection
9.4
27.1
56
60
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
3.3
26.8
137
419
4AC07
NOMESCO Finland
NA
97.2
26.7
29
*
RJ421
NOMESCO Finland
NA
10.1
26.1
52
52
L34
ICPC
Musculoskeletal, Blood test
25.9
26.1
36
14
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
23.3
26.0
37
16
R50.9
ICD-10 Finland
Fever, unspecified
1.7
25.7
641
4060
RT350
NOMESCO Finland
NA
21.9
25.6
37
17
NDM99
NOMESCO Finland
Other operation on fascia, ganglion, synovial sheath or bursa of wrist or hand
7.4
25.5
61
83
RJ512
NOMESCO Finland
NA
15.1
25.5
42
28
QDH05
NOMESCO Finland
Correction of deformity of toe nail
13.4
25.4
44
33
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.3
25.3
133
415
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
25.1
2107
17190
M66.0
ICD-10 Finland
Rupture of popliteal cyst
4.0
25.0
103
264
318
Kela drug reimbursment
Teriparatide
7.5
25.0
59
79
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
2.7
24.9
178
680
9531
FHL
Arthrodesis of the hand joint
10.5
24.7
48
46
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
5.3
24.7
76
145
J01MA12
ATC
levofloxacin; systemic
1.5
24.2
877
6091
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
3.6
24.1
112
318
ACC51
NOMESCO Finland
Release of median nerve
1.9
23.9
395
2202
9527
FHL
Alloarthroplasty, implant or endoprosthesis
87.1
23.7
26
*
L28
ICPC
Limited function/disability (L)
1.6
23.5
754
5088
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
2.6
23.4
182
728
NG1EA
NOMESCO Finland
Knee X-ray examination with wrench
3.7
23.4
104
285
NDG77
NOMESCO Finland
Other excision, reconstruction or fusion of joint of first finger
12.9
23.3
41
32
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
23.3
517
3167
RJ411
NOMESCO Finland
NA
7.0
23.1
57
82
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
2.1
23.0
254
1212
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
22.9
633
4114
ZX100
NOMESCO Finland
Oral
3.8
22.9
99
265
NDG20
NOMESCO Finland
Fusion of wrist, partial
6.3
22.8
61
98
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
2.1
22.7
275
1365
Z71.8
ICD-10 Finland
Other specified counselling
1.4
22.5
1120
8298
L95
ICPC
Osteoporosis
2.4
22.5
189
788
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
22.2
4741
44414
RJ210
NOMESCO Finland
NA
11.5
22.1
41
36
M05.2
ICD-10 Finland
Rheumatoid vasculitis
52.2
22.1
26
5
L50
ICPC
Musculoskeletal, Medication/prescr/renewal
7.7
22.0
51
67
H05AA02
ATC
teriparatide; parenteral
7.2
21.9
53
74
NHB10
NOMESCO Finland
Primary partial prosthetic replacement of ankle joint
20.1
21.6
32
16
RT274
NOMESCO Finland
NA
15.3
21.5
35
23
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
21.3
584
3785
RJ190
NOMESCO Finland
NA
13.9
21.2
36
26
7148X
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies
18.9
21.2
32
17
L99
ICPC
Musculoskeletal disease other
3.0
21.2
125
425
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
21.1
432
6610
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
21.1
1955
16067
NF1DA
NOMESCO Finland
X-ray of hips
2.8
21.0
139
509
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.8
20.9
370
2113
B01AB05
ATC
enoxaparin; parenteral
1.4
20.8
1495
11800
M17.4
ICD-10 Finland
Other secondary gonarthrosis, bilateral
7.2
20.7
50
70
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
20.7
1473
11606
4AB02
NOMESCO Finland
NA
10.9
20.6
39
36
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
2.8
20.6
132
474
RF212
NOMESCO Finland
NA
8.4
20.6
45
54
J05AB11
ATC
valaciclovir; oral
1.6
20.4
649
4361
M20.1
ICD-10 Finland
Hallux valgus (acquired)
1.7
20.4
461
2833
9289
FHL
Other measure in this category
20.1
20.3
30
15
NDL40
NOMESCO Finland
Repair of tendon of finger with transplant
8.5
19.8
43
51
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
7.5
19.6
46
62
M08.8
ICD-10 Finland
Other juvenile arthritis
105.4
19.6
21
*
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
2.3
19.5
181
795
M16.7
ICD-10 Finland
Other secondary coxarthrosis
4.8
19.5
65
137
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
19.3
835
6001
NH1AD
NOMESCO Finland
Ankle and foot CT
2.9
19.1
119
420
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
8.6
19.1
41
48
NBB10
NOMESCO Finland
Primary partial prosthetic replacement of humero-scapular joint not using cement, other or unspecified
5.5
18.9
56
103
B02.9
ICD-10 Finland
Zoster without complication
1.9
18.9
287
1551
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
4.0
18.8
76
193
J99.0
ICD-10 Finland
Rheumatoid lung disease
190.6
18.5
19
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.9
18.5
272
1457
Z50.1
ICD-10 Finland
Other physical therapy
1.9
18.4
280
1517
H16.0
ICD-10 Finland
Corneal ulcer
2.1
18.3
218
1075
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.5
18.2
150
622
QDH
NOMESCO Finland
Operations on toe nails
25.1
18.2
25
10
9283
FHL
Subtalar joint ossification surgery (or triple)
19.4
18.1
27
14
NC1AE
NOMESCO Finland
Elbow ultrasound examination
19.4
18.1
27
14
SPAT1255
SPAT
Intravenous administration of medicine
1.8
18.1
320
1822
J01CA04
ATC
amoxicillin; systemic
1.3
18.1
4096
37775
NHG20
NOMESCO Finland
Fusion of talocrural joint
5.8
18.1
51
89
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
17.7
340
1992
NH1FA
NOMESCO Finland
Weight-bearing X-ray of ankle
4.4
17.6
63
143
NHF70
NOMESCO Finland
Operation for debridement of joint of foot, open
36.8
17.6
22
6
J47
ICD-10 Finland
Bronchiectasis
2.9
17.5
107
374
115
Kela drug reimbursment
Breast cancer
0.5
17.5
166
3082
H26.3
ICD-10 Finland
Drug-induced cataract
5.8
17.5
49
85
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.8
17.4
294
1651
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.0
17.4
224
1142
WZA00
NOMESCO Finland
Short statement of of health and health related matters
1.9
17.2
277
1528
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
6.8
17.2
43
64
WW200
NOMESCO Finland
Immunization
2.4
17.1
143
600
L02BG04
ATC
letrozole; oral
0.5
17.0
101
2174
WX202
NOMESCO Finland
Supraclavicular plexus blockade
3.3
16.9
84
254
RF210
NOMESCO Finland
NA
2.3
16.9
153
665
NHK68
NOMESCO Finland
Shortening or lengthening osteotomy of ankle or foot
6.0
16.9
46
77
ZXA10
NOMESCO Finland
Bilateral
1.4
16.8
870
6456
L45
ICPC
Musculoskeletal, Observ/health educat/advice/diet
21.9
16.8
24
11
NBF15
NOMESCO Finland
Humeroscapular synovectomy, arthroscopic
8.4
16.6
36
43
WZA90
NOMESCO Finland
Other doctors statement
1.4
16.6
1050
8066
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
3.1
16.6
90
291
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
16.6
577
3948
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
3.0
16.6
98
336
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
16.4
514
3435
RS224
NOMESCO Finland
NA
6.7
16.3
41
62
A28
ICPC
Limited function/disability NOS
1.5
16.2
629
4410
M02AA07
ATC
piroxicam; topical
1.3
16.0
1812
15158
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
15.9
489
3252
M79.6
ICD-10 Finland
Pain in limb
1.3
15.8
1712
14235
N02BA01
ATC
acetylsalicylic acid; systemic, rectal
60.2
15.7
18
*
SPAT1153
SPAT
Removal of sutures
1.3
15.7
1538
12608
NHF15
NOMESCO Finland
Synovectomy of ankle, arthroscopic
11.2
15.7
29
26
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.6
15.7
440
2862
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
15.6
2507
21902
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.8
15.5
263
1480
L04AA14
ATC
[U] anakinra; parenteral
160.4
15.5
16
*
RF430
NOMESCO Finland
NA
8.5
15.4
33
39
NDG71
NOMESCO Finland
Arthrodes of first MP joint
8.9
15.4
32
36
M50.8
ICD-10 Finland
Other cervical disc disorders
5.5
15.3
45
83
A60
ICPC
General and Unspecified, Result test/procedure
2.0
15.3
204
1055
A02BA02
ATC
ranitidine; systemic
1.4
15.3
929
7083
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
15.2
3067
27500
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.0
15.2
184
917
N02AA05
ATC
oxycodone; systemic
1.5
15.2
623
4417
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
2.6
15.2
114
452
M95.8
ICD-10 Finland
Other specified acquired deformities of musculoskeletal system
23.4
15.1
21
9
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
15.0
798
5943
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.5
15.0
96
2015
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
3.7
14.9
64
173
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.9
14.9
91
318
R3130
NOMESCO Finland
Training in activities of daily lining
56.8
14.8
17
*
9260
FHL
Alloarthroplasty, endoprosthesis or implant
56.8
14.8
17
*
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.4
14.7
125
530
K07.60
ICD-10 Finland
Snapping jaw
1.9
14.7
224
1217
M65.9
ICD-10 Finland
Synovitis and tenosynovitis, unspecified
2.4
14.6
129
556
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.5
14.5
504
3448
NDG63
NOMESCO Finland
Arthroplasty of II-V MCP joint
150.4
14.5
15
*
L16
ICPC
Ankle symptom/complaint
1.5
14.3
448
2993
L08
ICPC
Shoulder symptom/complaint
1.4
14.3
880
6713
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
2.4
14.3
118
491
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.7
14.2
319
1958
ND1CG
NOMESCO Finland
Wrist and hand extensive MRI examination with high intensity magnet
3.9
14.2
58
151
RJ412
NOMESCO Finland
NA
9.7
14.2
28
29
A46
ICD-10 Finland
Erysipelas
1.5
14.1
571
4031
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
2.7
14.1
93
344
SPAT1325
SPAT
Vaccination
1.3
14.0
1584
13198
S20
ICPC
Corn/callosity
2.7
14.0
97
369
M01AB01
ATC
indometacin; systemic, rectal
1.7
13.9
321
1983
M05BA01
ATC
etidronic acid; systemic
5.0
13.9
44
89
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
13.9
721
5341
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
3.0
13.9
80
270
NCK10
NOMESCO Finland
Partial or total excision of bone of elbow or forearm, other location
17.6
13.8
21
12
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.6
13.8
96
367
RF421
NOMESCO Finland
NA
4.7
13.7
46
99
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
3.0
13.7
79
267
A02BB01
ATC
misoprostol; oral
5.0
13.6
43
87
RK221
NOMESCO Finland
NA
75.3
13.6
15
*
M06.2
ICD-10 Finland
Rheumatoid bursitis
75.3
13.6
15
*
RK224
NOMESCO Finland
NA
75.3
13.6
15
*
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.2
13.5
139
647
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
13.5
535
3765
G63.6*M05.3
ICD-10 Finland
Rheumatoid polyneuropathy
140.3
13.4
14
*
D64.9
ICD-10 Finland
Anaemia, unspecified
1.5
13.4
415
2761
L60
ICPC
Musculoskeletal, Result test/procedure
7.4
13.4
31
42
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
3.0
13.3
76
254
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.9
13.3
188
996
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
13.3
1057
8389
A10BA02
ATC
metformin; oral
0.7
13.2
767
9836
H16.9
ICD-10 Finland
Keratitis, unspecified
2.7
13.1
87
324
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
13.0
1790
15248
RJ120
NOMESCO Finland
NA
10.9
13.0
24
22
RF222
NOMESCO Finland
NA
28.4
12.9
17
6
NHK10
NOMESCO Finland
Incision or excision of metatarsal or tarsal bone
3.2
12.9
67
212
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
2.0
12.9
170
875
NHQ40
NOMESCO Finland
Amputation of toe
3.0
12.9
72
240
A04AA01
ATC
ondansetron; systemic, rectal
1.6
12.8
313
1964
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
12.8
1264
10326
NB1AD
NOMESCO Finland
Shoulder CT examination
2.8
12.8
82
299
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.3
12.8
114
495
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.6
12.8
375
2469
K02.1
ICD-10 Finland
Caries of dentine
1.2
12.7
2631
23448
NAG42
NOMESCO Finland
Posterior fusion of cervical spine with or without fixation
9.7
12.7
25
26
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
12.7
1333
10978
NDB20
NOMESCO Finland
Primary total prosthetic replacement of joint of wrist not using cement, all parts
70.0
12.6
14
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.7
12.6
259
1550
7143C
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SERONEGATIVA]
32.1
12.6
16
5
NCF15
NOMESCO Finland
Synovectomy of elbow joint, arthroscopic
24.3
12.4
17
7
M25.4
ICD-10 Finland
Effusion of joint
3.0
12.4
71
238
R60.0
ICD-10 Finland
Localized oedema
1.5
12.4
486
3413
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
12.3
1079
8669
RF110
NOMESCO Finland
NA
8.0
12.3
27
34
XG410
NOMESCO Finland
Flow-volume spirometry
1.9
12.2
187
1023
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
1.6
12.1
294
1848
NHL50
NOMESCO Finland
Tenolysis or tenosynovectomy of foot
4.5
12.0
41
91
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
7.2
12.0
28
39
NDL99
NOMESCO Finland
Other operation on muscle or tendon of wrist or hand
7.5
11.9
27
36
M05BX03
ATC
strontium ranelate; oral
3.7
11.9
50
135
NHL99
NOMESCO Finland
Other operation on muscle or tendon of ankle or foot
4.0
11.8
46
116
J01MA14
ATC
moxifloxacin; systemic
1.5
11.8
383
2583
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
11.8
970
7720
NF1AT
NOMESCO Finland
Puncture of hip joint with ultrasound guidance
4.9
11.7
37
76
SPAT1204
SPAT
Arthrocentesis
3.5
11.5
53
154
RJ126
NOMESCO Finland
NA
11.1
11.5
21
19
SBA10
NOMESCO Finland
Measurement of excretion of saliva
3.0
11.5
64
214
M66.2
ICD-10 Finland
Spontaneous rupture of extensor tendons
8.6
11.5
24
28
R03AC02
ATC
salbutamol; inhalant
1.2
11.5
2494
22247
RT340
NOMESCO Finland
NA
+∞
11.5
11
*
H02BX01
ATC
methylprednisolone, combinations; systemic
1.7
11.4
248
1507
9526
FHL
Autoarthroplasty (eg Vainio)
120.2
11.4
12
*
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
2.8
11.4
71
254
J01FA06
ATC
roxithromycin; oral
1.2
11.4
1946
16924
NHG70
NOMESCO Finland
Arthroplasty of first tarsometatarsal joint
2.3
11.4
99
427
R05
ICD-10 Finland
Cough
1.3
11.3
881
6954
RD211
NOMESCO Finland
NA
1.8
11.3
203
1167
L01BB01
ATC
NA
8.3
11.3
24
29
RT172
NOMESCO Finland
NA
9.6
11.2
22
23
WX002
NOMESCO Finland
Sedation and analgesia
1.3
11.2
898
7116
RF433
NOMESCO Finland
NA
12.7
11.1
19
15
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
3.9
11.1
44
113
M01AE52
ATC
naproxen and esomeprazole; oral
1.9
11.1
164
884
A55
ICPC
General and Unspecified, Local injection/infiltration
3.8
11.1
46
123
R06.0
ICD-10 Finland
Dyspnoea
1.3
11.1
1095
8927
RK120
NOMESCO Finland
NA
5.4
11.0
32
60
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
2.5
11.0
82
328
A01
ICPC
Pain general/multiple sites
1.5
11.0
326
2154
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.8
10.9
193
1104
M35.7
ICD-10 Finland
Hypermobility syndrome
2.8
10.9
66
234
RJ420
NOMESCO Finland
NA
5.3
10.8
32
61
QDA10
NOMESCO Finland
Incision of skin of lower limb
4.1
10.8
40
97
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
2.0
10.8
128
637
WX120
NOMESCO Finland
Intravenous local anesthesy of arm
2.5
10.8
80
319
71200
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis
9.6
10.7
21
22
E85.3
ICD-10 Finland
Secondary systemic amyloidosis
28.1
10.7
14
5
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.0
10.7
140
721
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
10.7
753
5855
M05.1
ICD-10 Finland
Rheumatoid lung disease
60.1
10.6
12
*
WX200
NOMESCO Finland
Interscalenous plexus blockade
2.3
10.5
97
433
M79.7
ICD-10 Finland
Fibromyalgia
1.9
10.5
153
821
SPAT1251
SPAT
Organisation of medication
1.9
10.4
157
854
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
3.6
10.4
46
130
I32.8*M05.3
ICD-10 Finland
Pericarditis (in) rheumatoid
+∞
10.4
10
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
10.4
1344
11307
KMAK
NOMESCO Finland
NA
1.2
10.3
2402
21488
1008
NOMESCO Finland
NA
12.0
10.3
18
15
TNC10
NOMESCO Finland
Joint puncture, elbow joint
32.6
10.3
13
*
0108
NOMESCO Finland
NA
32.6
10.3
13
*
SPAT1301
SPAT
No procedures
1.2
10.3
1423
12060
NGF10
NOMESCO Finland
Total synovectomy of knee, open
10.6
10.3
19
18
E0000UV
ATC
NA
1.2
10.2
1779
15452
NDB70
NOMESCO Finland
Prosthetic replacement of one IP joint
18.8
10.2
15
8
L88
ICD-10 Finland
Pyoderma gangrenosum
7.4
10.2
23
31
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
0.5
10.1
69
1410
A10AA01
ATC
NA
2.1
10.1
111
536
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
10.0
2363
21150
M01AB05
ATC
diclofenac; systemic, rectal
1.2
10.0
3299
30472
WX110
NOMESCO Finland
Local anesthesy
1.2
9.9
3323
30731
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
2.6
9.9
71
279
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
9.8
118
590
GD1AD
NOMESCO Finland
Thorax CT examination
1.7
9.8
186
1090
M02AA10
ATC
ketoprofen; topical
1.3
9.8
733
5748
J01DA01
ATC
[U] cefalexin; systemic
1.2
9.7
3035
27858
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
7.4
9.7
22
30
NHG26
NOMESCO Finland
Fusion between bones of ankle or ankle and foot
2.6
9.5
65
248
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.7
9.5
175
1017
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.1
9.5
107
521
H04AA01
ATC
glucagon; nasal, parenteral
2.4
9.5
81
347
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
9.1
9.5
19
21
R81
ICPC
Pneumonia
1.9
9.5
139
750
M01AB08
ATC
etodolac; oral
1.5
9.5
336
2309
B01AX06
ATC
[U] rivaroxaban; oral
2.0
9.5
111
550
7230B
ICD-9 Finland
Other disorders of cervical region, Spinal stenosis of cervical region[SUBLUXATIO ATLANTO-AXIALIS]
100.2
9.4
10
*
TNF10
NOMESCO Finland
Puncture of hip joint
7.5
9.4
21
28
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
2.4
9.4
78
332
L15
ICPC
Knee symptom/complaint
1.3
9.4
930
7567
NCC30
NOMESCO Finland
Secondary implantation of prosthesis in elbow joint, two parts
+∞
9.4
9
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
9.4
963
7873
ZZH40
NOMESCO Finland
Substitute of bone
2.9
9.4
54
185
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
9.3
1852
16272
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
9.3
1215
10221
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
2.6
9.3
64
247
M70.2
ICD-10 Finland
Olecranon bursitis
1.9
9.2
121
628
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
9.2
1547
13356
M15.3
ICD-10 Finland
Secondary multiple arthrosis
4.5
9.2
31
69
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
5.4
9.2
26
48
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.7
9.2
199
1214
J05AB01
ATC
aciclovir; systemic
1.3
9.1
947
7751
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.8
9.1
153
866
5BA08
NOMESCO Finland
NA
3.8
9.1
37
99
NH3CG
NOMESCO Finland
Extensive MRI of foot
3.8
9.1
37
99
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
4.6
9.1
30
66
RD210
NOMESCO Finland
NA
2.4
9.0
75
320
S42.2
ICD-10 Finland
Fracture of upper end of humerus
1.7
9.0
194
1185
SPAT1252
SPAT
Overall medication plan or its review
1.5
8.9
287
1931
NBB20
NOMESCO Finland
Primary total prosthetic replacement of humero-scapular joint
2.7
8.9
58
217
N05AF03
ATC
chlorprothixene; systemic
0.3
8.9
17
585
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
0.5
8.8
54
1144
PJA12
NOMESCO Finland
Sentinel node biopsy
0.6
8.8
183
2800
M35.1
ICD-10 Finland
Other overlap syndromes
4.4
8.7
30
69
H02AB02
ATC
dexamethasone; systemic
0.7
8.7
249
3583
NDT99
NOMESCO Finland
Other operation on wrist or hand
14.0
8.7
14
10
A02BC05
ATC
esomeprazole; systemic
1.2
8.7
1929
17098
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.2
8.6
82
374
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
8.5
3352
31217
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
1.9
8.5
117
621
N03AX16
ATC
pregabalin; oral
1.2
8.5
1063
8886
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
4.2
8.5
30
71
RJ530
NOMESCO Finland
NA
20.0
8.5
12
6
L29
ICPC
Musculoskeletal sympt/complt other
1.5
8.3
322
2254
9311
FHL
Knee cleansing surgery (synovectomy, debridement)
7.8
8.3
18
23
TEA00
NOMESCO Finland
Biopsy of lip
2.9
8.3
48
165
NBF10
NOMESCO Finland
Humeroscapular synovectomy, open
+∞
8.3
8
*
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
1.7
8.3
162
959
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
0.6
8.3
121
2003
M00.0
ICD-10 Finland
Staphylococcal arthritis and polyarthritis
8.5
8.3
17
20
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.8
8.2
132
737
N05AH03
ATC
olanzapine; systemic
0.5
8.2
78
1442
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.6
8.2
191
1190
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
0.6
8.2
89
1587
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
8.2
307
2139
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
8.1
1017
8492
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
8.1
797
6469
H16.8
ICD-10 Finland
Other keratitis
6.0
8.1
21
35
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
1.8
8.1
127
703
7143B
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SEROPOSITIVA]
33.4
8.1
10
*
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
2.0
8.0
92
455
NB1AT
NOMESCO Finland
Puncture of shoulder with ultrasound guidance
3.1
8.0
41
132
9477
FHL
Cleansing or splitting of a tendon or tendon sheath (eg tenosynovectomy, tenolysis)
4.0
8.0
30
75
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.9
8.0
117
633
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
2.5
8.0
60
244
J01AA02
ATC
doxycycline; systemic
1.2
8.0
3980
37715
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
8.0
2577
23537
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.0
8.0
102
525
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.0
7.9
95
476
B01AF01
ATC
rivaroxaban; oral
1.3
7.9
485
3684
M02.8
ICD-10 Finland
Other reactive arthropathies
4.7
7.9
25
53
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
7.9
1663
14640
R4180
SPAT
NA
4.5
7.8
26
58
RF220
NOMESCO Finland
NA
2.3
7.8
68
298
N05BA04
ATC
oxazepam; oral
0.8
7.8
766
9271
A03
ICPC
Fever
1.3
7.8
590
4628
ZZH32
NOMESCO Finland
Bone allograft, block
10.8
7.8
14
13
-50
ICPC
Medication/prescr/renewal
1.6
7.8
177
1099
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
0.3
7.8
20
594
M43.3
ICD-10 Finland
Recurrent atlantoaxial subluxation with myelopathy
45.0
7.7
9
*
A02BC01
ATC
omeprazole; systemic
1.2
7.7
1234
10576
ND1DA
NOMESCO Finland
Bilateral wrist X-ray examination
15.0
7.7
12
8
K08.3
ICD-10 Finland
Retained dental root
1.5
7.7
265
1813
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.0
7.7
87
429
9273
FHL
Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe
2.7
7.6
49
182
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
2.9
7.6
44
153
7165A
ICD-9 Finland
Other and unspecified arthropathies, Unspecified polyarthropathy or polyarthritis
18.4
7.6
11
6
G63.6
ICD-10 Finland
Polyneuropathy in other musculoskeletal disorders
25.0
7.6
10
*
M75.5
ICD-10 Finland
Bursitis of shoulder
1.9
7.5
99
517
-44
ICPC
Preventive immunization/medic
1.4
7.5
339
2445
NDG79
NOMESCO Finland
Other excision, reconstruction or fusion of joint of II-V finger
8.8
7.5
15
17
R5110
SPAT
NA
1.9
7.5
109
591
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.2
7.5
936
7811
XA402
NOMESCO Finland
ENMG
1.8
7.5
112
612
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.5
7.5
210
1374
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.4
7.4
299
2111
SPAT1260
SPAT
Consultation of another employee
1.3
7.4
772
6311
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
3.1
7.4
37
118
T89
ICPC
Diabetes insulin dependent
1.7
7.4
136
796
M11.2
ICD-10 Finland
Other chondrocalcinosis
4.5
7.4
24
53
A10AA02
ATC
NA
1.8
7.3
121
684
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
7.3
1825
16274
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
1.8
7.3
119
670
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.1
7.3
77
368
B01AB04
ATC
dalteparin; parenteral
1.6
7.3
199
1291
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
2.4
7.3
59
251
M45
ICD-10 Finland
Ankylosing spondylitis
2.1
7.3
80
391
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
1.6
7.3
177
1118
1XC0Y
NOMESCO Finland
NA
+∞
7.3
7
*
M14
ICD-10 Finland
Arthropathies in other diseases classified elsewhere
+∞
7.3
7
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
0.6
7.3
107
1767
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.1
7.3
75
357
NFC40
NOMESCO Finland
Repair of hip prosthesis by bone transplant to acetabulum
4.1
7.3
26
63
WX213
NOMESCO Finland
Lower leg blockade
3.3
7.2
34
104
NE1BA
NOMESCO Finland
Pelvis extensive X-ray examination
2.4
7.2
60
256
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
0.6
7.2
154
2341
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.2
7.2
1477
12950
WX290
NOMESCO Finland
Other blockade of nerve
1.2
7.1
1852
16570
4AB0X
NOMESCO Finland
NA
20.0
7.1
10
5
NH1DA
NOMESCO Finland
Bilateral ankle X-ray examination
20.0
7.1
10
5
TNH11
SPAT
NA
20.0
7.1
10
5
SPAT1216
SPAT
Assessment of functional ability
1.3
7.1
627
5019
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.0
7.1
83
417
N05AH02
ATC
clozapine; systemic
0.2
7.1
6
327
K11.7
ICD-10 Finland
Disturbances of salivary secretion
7.9
7.1
15
19
Z22.30
ICD-10 Finland
Latent tuberculosis
12.0
7.1
12
10
N05AH04
ATC
quetiapine; oral
0.8
7.1
387
5028
J01FA10
ATC
azithromycin; systemic
1.2
7.1
2715
25056
RS211
NOMESCO Finland
NA
4.5
7.1
23
51
GX1K5
NOMESCO Finland
Diffusion capacity
5.6
7.0
19
34
WX214
NOMESCO Finland
Plexus blockade at the ankle
3.7
7.0
28
75
N08.4*E85.9
ICD-10 Finland
Glomerular disorders in amyloidosis
10.0
7.0
13
13
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.4
7.0
323
2344
N04AA02
ATC
biperiden; systemic
0.3
7.0
11
416
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
7.0
557
4404
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
6.9
2620
24138
NDL32
NOMESCO Finland
Suture or reinsertion of tendon of wrist or hand, extensor tendon
2.6
6.9
46
177
RJ516
NOMESCO Finland
NA
13.8
6.9
11
8
J45.9
ICD-10 Finland
Asthma, unspecified
1.3
6.9
735
6024
ZZH22
NOMESCO Finland
Graft of patients own bone, block
3.5
6.9
30
87
A07AA02
ATC
nystatin; oral
1.5
6.8
257
1796
S01AD03
ATC
aciclovir; ophthalmic
1.6
6.8
146
895
N05AA02
ATC
levomepromazine; systemic
0.5
6.8
50
993
C03CA01
ATC
furosemide; systemic
1.2
6.8
1118
9597
7102B
ICD-9 Finland
Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM SECUNDARIUM]
10.9
6.8
12
11
K07
ICPC
Swollen ankles/oedema
1.6
6.8
165
1042
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
6.8
2180
19818
N05AX08
ATC
risperidone; systemic
0.6
6.8
124
1945
TNA11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, back or neck
16.7
6.7
10
6
I00
ICD-10 Finland
Rheumatic fever without mention of heart involvement
16.7
6.7
10
6
RF431
NOMESCO Finland
NA
16.7
6.7
10
6
QDH00
NOMESCO Finland
Avulsion of toe nail
4.7
6.7
21
45
TND11
SPAT
NA
7.2
6.7
15
21
RK260
NOMESCO Finland
NA
7.2
6.7
15
21
M08.2
ICD-10 Finland
Juvenile arthritis with systemic onset
22.5
6.7
9
*
ZX114
NOMESCO Finland
Intramuscular
2.1
6.6
68
324
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.4
6.6
262
1849
J94.8
ICD-10 Finland
Other specified pleural conditions
2.2
6.6
62
282
NGC30
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, special prosthesis
3.0
6.6
35
117
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.5
6.6
246
1711
N05AD01
ATC
haloperidol; systemic
0.4
6.6
24
614
TEG00
NOMESCO Finland
Punction of mandibular joint
6.4
6.6
16
25
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.1
6.6
69
329
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.0
6.6
74
365
R11
ICD-10 Finland
Nausea and vomiting
1.4
6.6
304
2206
C07AA05
ATC
propranolol; systemic
0.8
6.6
558
6869
EBA00
NOMESCO Finland
Extraction of tooth
1.2
6.6
1365
11963
L55
ICPC
Musculoskeletal, Local injection/infiltration
12.2
6.6
11
9
J01MA02
ATC
ciprofloxacin; systemic
1.2
6.6
1686
15043
S22.3
ICD-10 Finland
Fracture of rib
1.5
6.6
234
1618
R05
ICPC
Cough
1.2
6.6
952
8066
RF310
NOMESCO Finland
NA
3.9
6.5
25
65
A98
ICPC
Health maint/preventive medicine
1.3
6.5
5152
50372
E11
ICD-10 Finland
Type 2 diabetes mellitus
0.8
6.5
388
4985
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
0.5
6.5
66
1194
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.3
6.5
436
3365
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
3.9
6.5
24
61
I30.9
ICD-10 Finland
Acute pericarditis, unspecified
3.6
6.5
27
76
4AA12
NOMESCO Finland
NA
5.3
6.4
18
34
RF214
NOMESCO Finland
NA
5.7
6.4
17
30
M86.1
ICD-10 Finland
Other acute osteomyelitis
5.7
6.4
17
30
N07BB01
ATC
disulfiram; oral
0.5
6.4
48
949
ZZH30
NOMESCO Finland
Bone allograft
14.3
6.4
10
7
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
1.9
6.4
85
447
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
2.5
6.3
45
178
K05.31
ICD-10 Finland
Periodontitis pronounced
1.3
6.3
394
3006
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.6
6.3
146
913
RJ414
NOMESCO Finland
NA
5.5
6.3
17
31
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.0
6.3
76
386
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.1
6.3
67
324
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
1.7
6.3
129
783
RJ425
NOMESCO Finland
NA
9.2
6.3
12
13
NHF10
NOMESCO Finland
Synovectomy of ankle, open
18.0
6.3
9
5
9508
FHL
Tendon or muscle transposition
18.0
6.3
9
5
M81.4
ICD-10 Finland
Drug-induced osteoporosis
3.7
6.3
25
68
ZZH20
NOMESCO Finland
Graft of patients own bone
3.7
6.3
25
68
NBB15
NOMESCO Finland
Primary bipolar prosthetic replacement of humero-scapular joint
26.7
6.2
8
*
9252
FHL
Plaster bandage placement or replacement (no fracture) in the operating room
7.0
6.2
14
20
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
6.2
1053
9057
A10BH01
ATC
sitagliptin; oral
0.7
6.2
199
2797
T90
ICPC
Diabetes non-insulin dependent
0.8
6.1
670
8031
N06AB10
ATC
escitalopram; oral
0.8
6.1
554
6770
I25.2
ICD-10 Finland
Old myocardial infarction
1.5
6.1
212
1457
WX212
NOMESCO Finland
Femoral plexus blockade
2.0
6.1
73
372
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.5
6.1
219
1518
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
1.8
6.1
97
547
ZZA00
NOMESCO Finland
Split skin graft
1.8
6.1
104
598
EG1AA
NOMESCO Finland
Mandibular joint X-ray examination
3.8
6.1
23
60
SPAT1254
SPAT
Administration of medicine
1.3
6.0
557
4486
TQX00
NOMESCO Finland
Needle biopsy of skin
8.6
6.0
12
14
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
2.9
6.0
33
114
NH1DG
NOMESCO Finland
Ankle and foot very extensive MRI examination with high intensity magnet
4.9
6.0
18
37
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
0.5
6.0
51
973
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3856
22937
2.74
322.83
2.6
2.2
nmol/l
79.0
78.5
0.54
3685
20527
(3010144) Erythrocytes [#/volume] in Synovial fluid
381
409
9.85
322.23
1.7
1.3
e6/l
22526.0
131588.9
2.20
286
272
(3011397) Hemoglobin [Presence] in Urine by Test strip
2529
12400
2.73
309.00
6.1
3.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
3129
8836
6.02
307.65
1.5
1.2
u/ml
110.0
2.8
153.22
1625
3357
(3013115) Eosinophils [#/volume] in Blood
5768
27160
13.60
307.65
15.3
5.5
e9/l
0.2
0.2
1.86
5538
23663
(3009261) Glucose [Presence] in Urine by Test strip
4547
26367
3.57
307.65
6.1
3.7
estimate
0.0
0.0
1.57
1124
4694
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
1548
1281
15.67
307.65
1.6
1.6
iu/ml
9.2
6.2
0.11
365
252
(3021788) Differential panel - Synovial fluid
719
806
9.94
307.65
1.7
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
5842
30638
12.70
307.65
18.4
8.6
e9/l
4.0
4.1
2.95
5575
26590
(3021440) Promyelocytes/100 leukocytes in Blood
1568
4147
4.70
307.65
6.1
3.9
%
0.1
0.2
1.35
321
1169
(3002179) Metamyelocytes/100 leukocytes in Blood
1515
3967
4.71
307.65
5.3
3.8
%
0.3
0.6
6.41
257
914
(3006315) Basophils [#/volume] in Blood
5753
26230
14.03
307.65
14.9
5.3
e9/l
0.0
0.0
16.12
5477
22428
(3005719) IgG [Mass/volume] in Serum or Plasma
1406
3815
4.45
307.65
3.9
2.7
g/l
10.0
10.6
6.51
1358
3467
(3002030) Lymphocytes/100 leukocytes in Blood
5245
25270
7.26
307.65
15.7
5.6
%
27.6
28.1
2.64
5158
23400
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1734
6641
3.22
307.65
1.3
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
5984
40063
9.96
307.65
12.8
3.8
mm/h
15.0
12.5
33.63
5905
36962
(3037522) Nuclear Ab [Titer] in Serum
2541
7116
5.29
307.65
1.4
1.3
titre
481.3
554.9
1.20
718
1512
(3018010) Neutrophils/100 leukocytes in Blood
5232
24909
7.33
307.65
15.1
5.4
%
57.7
57.1
3.59
5147
23163
(3035350) Ketones [Presence] in Urine by Test strip
4529
25960
3.61
307.65
6.0
3.6
estimate
0.0
0.0
0.88
1102
4717
(3044941) Cell count panel - Synovial fluid
566
706
8.71
307.65
1.6
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
423
394
11.43
307.65
1.8
1.4
%
35.2
28.9
1.99
279
229
(3006504) Eosinophils/100 leukocytes in Blood
5236
24505
7.56
307.65
15.4
5.5
%
2.8
2.8
0.23
5152
22703
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
3032
9398
5.27
307.65
1.5
1.3
iu/ml
112.6
20.3
111.01
2226
2733
(3021589) Normoblasts [#/volume] in Blood
4145
23370
3.24
307.65
17.8
9.0
e9/l
0.0
0.0
2.05
3785
18950
(42870588) Differential panel, method unspecified - Blood
4298
17707
5.44
307.65
12.9
5.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
544
534
11.05
307.65
1.8
1.5
%
53.9
59.4
1.71
360
319
(3023420) DNA double strand Ab [Units/volume] in Serum
520
475
11.84
307.65
1.3
1.5
iu/ml
20.2
23.6
—
9
28
(3015736) pH of Urine
3593
20154
2.81
307.65
5.5
3.4
—
5.7
—
0
14
(3000475) Leukocytes [#/volume] in Synovial fluid
958
1070
10.37
307.65
1.9
1.5
e6/l
10741.9
13002.4
0.68
764
743
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
1022
1187
10.07
307.65
1.7
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
5189
23753
7.56
307.65
15.5
5.5
%
0.8
0.7
47.29
5105
22027
(3025159) Blasts/100 leukocytes in Blood
1527
3892
4.85
307.65
6.1
3.9
%
0.0
0.4
1.65
285
981
(3021601) Nitrite [Presence] in Urine by Test strip
4530
26088
3.59
307.65
7.7
4.9
estimate
0.0
0.0
0.80
1133
4764
(3019198) Lymphocytes [#/volume] in Blood
5746
26851
13.30
307.65
15.0
5.3
e9/l
1.8
1.9
11.88
5516
23446
(3001604) Monocytes [#/volume] in Blood
5735
26111
13.67
307.65
14.8
5.3
e9/l
0.6
0.6
8.12
5452
22333
(3037467) Urinalysis macro (dipstick) panel - Urine
5512
36834
4.83
307.65
8.5
4.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1588
5254
3.70
307.65
1.3
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
1611
4363
4.61
307.65
6.0
3.9
%
0.7
0.9
2.20
340
1263
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
5886
41674
6.84
307.65
12.7
7.4
u/l
72.8
78.3
34.45
5820
39111
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1316
3349
4.70
307.65
1.2
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
2872
11433
3.77
307.65
8.9
4.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
5240
24642
7.53
307.65
16.0
5.7
%
9.2
8.5
55.12
5158
22961
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
207
102
20.95
273.51
1.4
2.1
mg/l
8.2
9.9
1.82
154
84
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
185
71
26.81
269.42
1.3
1.8
au/ml
74.5
145.0
—
23
10
(40758558) Short blood count panel - Blood
2590
13533
2.55
269.42
12.2
6.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
968
3033
3.59
255.62
1.8
1.9
g/l
1.2
1.4
2.56
907
2749
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
504
994
5.42
243.48
4.1
3.6
%
57.1
57.7
0.46
504
994
(3018095) Leukocytes [#/volume] in Urine
3126
18582
2.35
234.97
4.4
3.6
e6/l
55.8
105.7
4.83
2067
13009
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
637
1596
4.33
230.05
1.7
1.8
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
746
2098
3.90
230.01
1.2
1.3
u/ml
0.3
1.3
3.28
79
204
(3034891) Synovial lining cells/100 cells in Synovial fluid
231
202
11.83
224.68
1.6
1.5
%
4.0
5.0
0.28
59
39
(3029937) Albumin [Presence] in Urine by Test strip
2500
14003
2.30
209.91
7.6
4.1
estimate
0.0
0.0
1.70
1138
4641
(3026493) Urate [Moles/volume] in Serum or Plasma
2427
13773
2.24
193.82
2.3
2.5
umol/l
1753.8
4712.3
6.20
2191
11820
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
525
1363
4.11
179.66
1.2
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
934
3693
2.79
161.52
4.8
2.8
e9/l
3.9
4.1
1.19
723
2861
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
3039
20082
1.99
150.72
7.0
3.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
381
920
4.34
143.02
1.1
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
6077
53427
4.40
136.22
26.8
13.7
mg/l
17.2
23.3
65.37
5687
42139
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
84
23
37.00
135.34
1.6
1.7
mg/l
1.3
1.5
0.38
69
14
(46235355) HIV 1 and 2 tests - Meaningful Use set
1477
7773
2.17
133.81
1.5
1.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
179
227
8.09
131.99
2.8
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1382
7247
2.16
125.36
2.3
2.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
136
132
10.51
123.03
1.7
1.2
%
47.7
58.7
2.00
126
109
(3000850) Epithelial cells [#/volume] in Urine
1834
10985
1.94
113.59
2.8
2.6
e6/l
5.1
6.2
1.66
1656
9578
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
444
1397
3.34
113.23
1.2
1.3
u/ml
5.6
7.4
0.31
75
239
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
438
1381
3.33
111.29
1.2
1.3
u/ml
7.9
4.8
0.31
57
151
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3652
27197
1.81
111.13
6.3
6.6
mmol/l
1.2
1.2
2.28
3130
22854
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
461
1525
3.18
108.18
1.2
1.3
u/ml
54.2
38.9
0.43
35
96
(3018418) pH of Serum or Plasma
2433
16204
1.81
106.34
3.4
4.0
ph
7.4
7.4
1.15
481
3083
(3041096) Erythrocytes [Presence] in Urine by Automated
2158
13947
1.83
103.47
5.3
3.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
369
1134
3.39
97.48
1.2
1.2
u/ml
11.1
16.3
—
6
18
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
368
1133
3.39
96.92
1.2
1.2
u/ml
9.4
3.6
0.77
36
83
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3319
24627
1.73
96.44
5.6
5.8
mmol/l
1.2
1.2
2.17
3128
22203
(3002582) Erythrocytes [#/volume] in Urine
2344
15825
1.76
95.04
3.5
3.2
e6/l
56.0
68.7
0.27
1927
12008
(3030467) Casts [#/volume] in Urine by Automated count
2197
14585
1.78
94.24
3.5
3.1
e6/l
0.4
0.4
0.71
1775
10866
(3019150) Specific gravity of Urine by Refractometry
1804
11345
1.83
92.51
8.2
4.1
kg/l
1.0
1.0
1.75
221
1716
(36304419) Bacteria [Presence] in Urine
2132
14170
1.76
90.17
3.3
3.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2017
13234
1.77
88.96
2.5
2.2
mg/l
3.4
2.9
11.15
1814
11285
(3045414) Leukocytes [Presence] in Urine
577
2418
2.53
86.24
2.3
1.9
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
431
1561
2.89
85.86
1.6
1.6
g/l
0.2
0.2
5.30
408
1469
(40761535) Cells panel - Urine sediment
872
4390
2.14
84.87
6.9
3.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
5148
44063
1.90
83.95
30.1
16.8
%
14.2
13.7
101.83
5113
43101
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
435
1622
2.81
82.01
1.6
1.6
g/l
1.1
1.2
2.29
414
1527
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
184
390
4.83
80.97
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
184
390
4.83
80.97
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
184
391
4.82
80.73
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
184
394
4.78
79.99
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
184
394
4.78
79.99
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
184
394
4.78
79.99
1.2
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1456
8954
1.81
78.30
2.8
2.7
e6/l
1.0
1.2
1.53
977
5017
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
433
1674
2.70
76.03
2.7
2.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
2035
13878
1.69
75.32
4.6
4.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
831
4362
2.04
71.58
1.8
2.6
g/l
66.6
66.5
0.17
771
3964
(3007164) IgA [Mass/volume] in Serum or Plasma
1596
10307
1.73
71.53
1.6
1.5
g/l
2.8
2.4
9.87
1126
6125
(3004588) Protein electrophoresis panel - Serum or Plasma
722
3624
2.12
70.05
1.7
2.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
282
902
3.23
69.59
1.7
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
166
367
4.62
69.40
1.6
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
1001
5671
1.91
68.94
2.7
2.4
%
1.8
1.8
0.57
902
5013
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
325
1140
2.95
68.40
1.2
1.3
u/ml
72.0
40.3
2.29
49
132
(3009445) Proteinase 3 Ab [Units/volume] in Serum
495
2206
2.35
64.05
1.3
1.6
u/ml
8.4
14.5
—
7
55
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
89
122
7.38
61.34
1.5
1.3
%
39.8
34.1
0.61
62
80
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
368
1483
2.57
59.19
1.7
1.7
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
221
677
3.35
58.47
1.2
1.3
u/ml
47.5
52.5
0.10
17
52
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
276
966
2.94
58.25
1.7
1.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1278
8198
1.70
56.86
2.2
2.5
umol/l
11.5
13.0
11.03
1202
7594
(3009871) Measles virus Ab [Titer] in Serum
91
142
6.49
55.67
1.8
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
6079
56983
2.67
53.81
26.9
10.2
u/l
25.0
25.6
2.71
6040
54887
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
250
874
2.94
52.85
1.5
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
204
657
3.18
49.73
1.3
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
436
2061
2.20
48.71
1.7
2.3
g/l
7.8
7.4
3.29
329
1552
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
435
2056
2.20
48.62
1.7
2.3
g/l
4.1
3.8
5.12
323
1476
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
435
2058
2.20
48.50
1.7
2.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
207
685
3.09
48.20
1.5
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
5553
50717
1.77
47.66
20.9
13.0
ml/min/173m2
83.8
80.0
41.84
5007
41834
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
423
2001
2.19
47.15
2.0
2.0
ug/l
1.2
1.9
1.14
376
1772
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
412
1933
2.21
46.86
1.7
2.3
g/l
3.3
3.1
5.07
325
1512
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
199
659
3.09
46.28
1.5
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
233
849
2.81
45.64
2.8
3.3
%
1.2
1.4
0.35
186
655
(3001729) Color of Synovial fluid
44
35
12.65
45.17
2.3
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
293
1205
2.50
45.05
1.6
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
733
4274
1.81
44.73
2.0
2.6
e9/l
71.9
69.8
0.83
552
3216
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
342
1537
2.30
43.11
1.7
2.2
g/l
0.0
0.0
0.86
317
1405
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
923
5802
1.69
43.11
2.8
4.3
u/l
252.1
243.9
0.87
873
5476
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
373
1750
2.20
42.37
1.8
2.4
g/l
0.7
0.9
0.75
332
1512
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
266
1076
2.54
42.35
1.5
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
398
1922
2.14
42.03
1.6
2.3
g/l
10.9
10.2
2.26
343
1617
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
211
763
2.83
41.93
1.5
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
278
1169
2.44
40.73
1.7
1.6
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
78
143
5.51
40.54
1.3
1.1
g/l
40.6
39.4
0.24
49
72
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
367
1748
2.17
40.12
1.6
1.6
titre
404.5
228.4
0.51
22
79
(3007853) Bacteria identified in Skin by Aerobe culture
945
6105
1.64
39.44
2.0
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
187
656
2.91
39.30
1.5
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1220
8386
1.56
39.25
2.1
1.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1060
7054
1.60
39.19
2.3
2.5
%
19.9
22.5
8.72
912
6009
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
141
420
3.41
39.04
1.2
1.2
u/ml
78.4
79.8
0.02
12
21
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
141
423
3.39
38.61
1.2
1.2
u/ml
52.7
35.6
0.43
16
35
(3021960) Folate [Moles/volume] in Serum or Plasma
1680
12450
1.48
37.60
1.6
1.5
nmol/l
22.0
20.9
0.89
1457
10587
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1115
7577
1.57
37.54
2.2
2.5
g/l
2.3
2.3
4.88
1053
7010
(3035611) Eosinophils/100 leukocytes in Synovial fluid
37
30
12.40
37.51
2.6
1.4
%
0.3
1.0
0.60
29
19
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
339
1613
2.16
37.13
1.6
2.2
g/l
36.8
37.8
2.56
300
1385
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
134
401
3.39
36.85
1.2
1.2
u/ml
2.6
4.0
—
7
28
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
436
2285
1.98
36.78
1.4
1.7
g/l
1.6
1.6
0.66
371
1955
(3031040) Bacteria [#/volume] in Urine by Automated count
4102
35762
1.42
36.34
5.4
4.5
e6/l
843.8
1547.4
0.88
63
468
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
882
5719
1.63
36.02
2.0
1.7
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
311
1447
2.21
36.02
1.6
2.3
g/l
0.0
0.0
0.00
286
1321
(3008898) HLA-B27 [Presence]
352
1721
2.11
35.93
1.0
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
306
1423
2.21
35.48
1.6
2.3
g/l
0.0
0.0
0.00
285
1318
(3024561) Albumin [Mass/volume] in Serum or Plasma
2847
23391
1.39
35.37
4.2
4.7
g/l
34.4
35.5
21.34
2641
21667
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
300
1395
2.21
34.79
1.5
1.4
iu/ml
14.7
15.0
0.01
11
37
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
213
857
2.54
34.30
1.9
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
858
5730
1.58
30.62
1.9
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
199
822
2.47
30.33
1.3
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2768
23048
1.36
29.77
2.9
2.8
ug/l
135.5
122.6
1.55
2601
21289
(3014051) Protein [Presence] in Urine by Test strip
264
1242
2.17
29.74
2.9
2.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
144
517
2.83
29.08
2.7
3.3
%
57.7
57.0
0.14
92
333
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
60
118
5.12
28.92
1.7
2.6
au/ml
245.8
111.5
0.89
14
18
(44806118)
150
553
2.75
28.81
1.3
1.4
—
—
—
0
0
(44790049)
150
553
2.75
28.81
1.3
1.4
—
—
—
0
0
(44790047)
150
553
2.75
28.81
1.3
1.4
—
—
—
0
0
(44790048)
150
553
2.75
28.81
1.3
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
169
662
2.60
28.80
2.4
2.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
73
170
4.33
28.73
1.1
1.5
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
62
127
4.92
28.53
1.7
3.1
mg/l
6.2
7.4
0.54
40
103
(3037756) Immunofixation for Serum or Plasma
233
1071
2.22
27.81
1.3
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
1362
10220
1.42
27.05
3.0
2.8
mosm/kgh2o
522.3
532.6
1.08
1184
8667
(3008757) Leukocyte morphology finding [Identifier] in Blood
147
564
2.64
26.15
2.9
3.9
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
732
4949
1.54
24.40
1.8
2.2
nmol/l
346.7
374.0
3.08
685
4533
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
139
539
2.61
24.24
1.9
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
312
1683
1.90
24.08
2.1
3.3
mg/l
48.4
89.1
0.62
265
1356
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
131
496
2.68
23.96
1.9
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
211
991
2.17
23.90
3.4
5.4
iu/ml
282.4
496.2
0.68
18
140
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
311
1683
1.89
23.76
2.1
3.3
mg/l
36.0
52.6
1.14
264
1358
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
303
1628
1.90
23.67
2.1
3.3
ratio
3.6
2.0
0.30
32
138
(3022621) pH of Urine by Test strip
555
3554
1.62
23.36
4.3
3.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
162
705
2.33
22.07
3.0
2.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1299
9972
1.38
21.95
1.8
1.8
nmol/l
1161.2
1172.8
0.19
1052
7542
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
117
446
2.65
21.16
1.9
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
117
446
2.65
21.16
1.9
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
117
446
2.65
21.16
1.9
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
664
4539
1.52
20.89
5.0
4.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
57
141
4.07
20.81
1.2
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1104
8316
1.40
20.78
3.2
2.8
e6/l
2.6
3.0
0.56
630
4406
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
31
45
6.92
20.34
1.1
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
875
6356
1.44
20.19
1.5
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
91
313
2.94
19.99
1.6
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
120
478
2.54
19.87
4.0
3.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
174
827
2.14
19.19
1.5
1.6
g/l
0.8
0.7
0.28
135
617
(3026008) Bacteria identified in Urine by Culture
2042
17053
1.29
18.76
3.6
3.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
236
1265
1.90
18.61
2.1
3.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
6099
59163
1.84
18.53
39.5
20.5
e9/l
265.1
254.0
33.55
6034
57651
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
183
905
2.05
18.19
1.3
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
6099
59187
1.82
18.16
39.2
20.4
pg
30.7
30.3
55.80
6070
58349
(3024731) MCV [Entitic volume]
6099
59187
1.82
18.16
39.2
20.4
fl
93.1
91.1
179.31
6071
58350
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
553
3744
1.52
18.12
2.3
2.4
au/ml
29.6
23.9
0.44
17
207
(3010813) Leukocytes [#/volume] in Blood
6100
59202
1.83
18.12
39.4
20.5
e9/l
6.9
6.7
11.07
6017
57512
(3026361) Erythrocytes [#/volume] in Blood
6099
59194
1.82
18.05
39.4
20.5
e12/l
4.3
4.5
125.10
6016
57512
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
127
544
2.36
18.01
1.6
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1839
15224
1.29
17.88
3.0
2.9
ng/l
1400.7
1272.9
0.71
1637
13043
(3000963) Hemoglobin [Mass/volume] in Blood
6099
59207
1.82
17.84
39.6
20.6
g/l
131.3
134.2
59.55
6072
58380
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
812
5943
1.42
17.83
7.8
7.0
kpa
5.0
5.1
2.57
782
5663
(3027801) Oxygen [Partial pressure] in Arterial blood
811
5941
1.42
17.72
7.8
7.0
kpa
11.8
12.4
2.74
779
5659
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1967
16445
1.28
17.66
2.0
2.1
u/l
147.9
208.3
3.07
1862
15378
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
509
3412
1.53
17.46
1.2
1.3
au/ml
48.9
51.4
0.12
17
156
(3011412) CD3 cells [#/volume] in Blood
116
484
2.42
17.45
2.3
2.4
e9/l
1.0
1.1
0.78
63
292
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
222
1195
1.89
17.30
1.3
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
646
4561
1.46
17.20
3.3
3.7
mmol/l
1.2
1.2
1.41
595
3966
(3016502) Oxygen saturation in Arterial blood
730
5279
1.43
17.10
8.1
7.5
%
94.9
95.8
2.79
707
5078
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
79
277
2.88
16.83
1.7
1.5
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
120
519
2.34
16.68
1.4
1.3
g/l
6.9
6.8
0.17
92
354
(3019060) Gas panel - Arterial blood
503
3408
1.52
16.40
4.7
5.0
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
119
518
2.32
16.31
1.4
1.3
g/l
2.6
2.9
0.89
90
355
(3024139) IgG subclass 3 [Mass/volume] in Serum
119
518
2.32
16.31
1.4
1.3
g/l
0.4
0.4
0.37
91
354
(3003396) Base excess in Arterial blood by calculation
800
5929
1.40
16.27
7.9
7.1
mmol/l
1.3
1.1
0.69
648
4651
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2578
22437
1.25
16.11
2.0
2.0
pmol/l
92.9
96.9
4.10
1450
11239
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
78
280
2.81
15.93
1.8
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
2199
18828
1.26
15.76
2.6
3.4
mmol/l
2.3
2.4
7.87
1967
16320
(4062490)
118
520
2.29
15.73
1.4
1.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
98
398
2.49
15.67
1.8
2.3
%
45.4
41.6
0.42
18
51
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
130
601
2.19
15.45
1.2
1.2
u/l
58.0
62.1
0.38
105
405
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
89
348
2.58
15.41
2.0
2.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
255
1493
1.74
15.10
1.2
1.2
titre
1818.6
907.6
—
7
55
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
246
1426
1.75
15.09
1.4
2.0
mg/l
11.4
11.5
0.03
223
1313
(3044927) Protein electrophoresis panel - Urine
117
524
2.26
15.04
1.2
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1554
18580
0.78
14.98
2.6
2.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3155
28282
1.23
14.40
5.2
6.2
umol/l
9.8
11.0
10.39
3013
26795
(3028433) Virus identified in Specimen by Culture
52
158
3.31
14.18
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
421
6108
0.67
14.14
1.6
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
2453
21472
1.23
13.87
7.5
8.8
inr
1.2
1.2
1.81
776
6123
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1257
10213
1.29
13.52
2.6
3.0
mmol/l
2.5
2.5
0.84
1113
8913
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
66
238
2.79
13.43
4.5
3.8
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
85
350
2.45
13.27
1.2
1.2
u/l
72.5
87.4
1.27
78
306
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
346
2281
1.55
12.80
1.4
2.0
u/l
37.0
39.6
1.55
302
2013
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
539
3883
1.42
12.80
1.6
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
444
3097
1.47
12.53
1.9
1.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
87
372
2.36
12.52
2.0
2.1
%
15.2
14.9
0.05
29
159
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
81
336
2.43
12.47
1.2
1.2
u/l
17.6
22.5
0.65
73
285
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
90
393
2.31
12.35
1.7
1.5
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
88
382
2.32
12.25
2.0
2.1
%
72.7
72.8
0.01
82
363
(3030981) Hyaline casts [#/volume] in Urine by Automated count
387
2642
1.50
12.16
2.8
2.7
e6/l
0.2
0.3
3.85
382
2566
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
62
229
2.72
12.10
1.2
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
653
4914
1.37
11.95
8.8
7.8
g/l
117.9
120.8
3.28
632
4728
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
586
4342
1.39
11.80
3.2
2.6
ml/min/173m2
67.7
65.3
0.74
227
1718
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
79
333
2.39
11.76
1.3
1.3
u/l
21.7
11.9
3.41
73
304
(3006184) Hemoglobin [Mass/volume] in Capillary blood
195
1142
1.73
11.62
2.7
2.2
g/l
121.4
127.7
2.79
125
815
(3017704) Immunofixation for Urine
71
287
2.49
11.58
1.2
1.5
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
93
424
2.21
11.55
1.4
1.4
u/l
704.6
347.6
3.00
88
402
(3000330) Specific gravity of Urine by Test strip
389
2691
1.47
11.46
3.6
3.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
78
332
2.37
11.38
2.6
2.5
e6/l
508.1
731.3
2.55
39
147
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
78
333
2.36
11.31
2.6
2.5
e6/l
381.4
541.9
2.51
61
282
(3007566) Smooth muscle Ab [Titer] in Serum
239
1489
1.63
11.28
1.1
1.2
titre
114.7
149.8
0.33
15
135
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
298
4431
0.66
11.24
1.5
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
5748
55623
1.36
11.13
20.2
13.2
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
125
650
1.94
10.95
1.4
1.5
g/l
37.4
32.5
3.27
114
584
(3012441) Differential panel - Pleural fluid
100
480
2.10
10.93
1.5
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
178
2954
0.59
10.85
1.4
1.4
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
95
449
2.13
10.81
1.3
1.4
mmol/l
5.8
6.4
0.76
79
420
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
414
2935
1.44
10.73
1.6
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
66
270
2.46
10.53
2.9
2.6
%
47.7
39.3
1.85
19
96
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
74
319
2.34
10.52
2.6
2.5
e9/l
0.2
0.2
0.46
61
279
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
61
243
2.52
10.30
2.9
3.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
63
255
2.49
10.29
1.1
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2814
25461
1.19
10.16
4.2
4.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
203
1249
1.65
10.11
3.0
3.1
mmol/l
24.7
25.0
0.65
172
1095
(3037121) Protein [Mass/volume] in Urine
272
1796
1.54
10.05
2.6
3.0
g/l
0.3
0.3
0.06
119
681
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
103
518
2.00
9.97
1.2
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
138
767
1.82
9.89
2.0
2.5
u/ml
508.2
1356.2
—
9
43
(3052851) Hemolysis interference index of Serum or Plasma
248
1611
1.56
9.86
3.1
3.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
380
2696
1.44
9.83
10.2
8.9
mmol/l
24.9
24.3
2.91
353
2523
(21494814) CD8 cells/100 lymphocytes in Specimen
54
208
2.61
9.78
1.7
2.1
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
46
165
2.80
9.56
1.6
2.1
u/ml
220.8
21037.6
—
9
24
(3023199) Leukocytes [#/volume] in Pleural fluid
110
575
1.93
9.55
1.5
1.5
e6/l
4432.6
1862.3
1.01
74
418
(3013826) Glucose [Moles/volume] in Serum or Plasma
3409
31465
1.18
9.46
4.9
4.5
mmol/l
6.6
6.7
0.70
3243
29371
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
79
368
2.16
9.39
1.7
1.6
u/l
7.6
5.8
0.25
52
176
(3014007) Fractional oxyhemoglobin in Arterial blood
441
3238
1.39
9.38
9.9
8.7
%
93.1
94.0
1.66
436
3227
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1411
12046
1.22
9.38
1.7
1.7
mg/l
1.5
1.2
2.81
1144
9202
(3000093) Morphology [Interpretation] in Blood Narrative
94
469
2.02
9.33
1.1
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
5721
55535
1.31
9.08
18.7
16.2
mmol/l
3.9
4.0
12.48
5587
54084
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
110
1959
0.55
8.77
1.5
1.7
mg/l
6.3
3.5
0.80
72
1403
(3019550) Sodium [Moles/volume] in Serum or Plasma
5704
55392
1.30
8.68
18.6
16.0
mmol/l
139.3
139.7
25.59
5585
54051
(3028308) Erythrocytes [#/volume] in Pleural fluid
99
518
1.93
8.61
1.5
1.4
e6/l
41699.3
72336.0
0.66
50
300
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
111
605
1.85
8.53
1.0
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
436
3249
1.37
8.49
7.3
7.0
mmol/l
24.4
24.7
0.74
402
3022
(40768806) Pleura Pathology biopsy report
98
515
1.92
8.43
1.5
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
118
661
1.80
8.31
1.2
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
60
266
2.27
8.09
2.2
1.8
u/field
2.8
2.5
0.10
36
189
(3014148) Varicella zoster virus Ab [Titer] in Serum
103
561
1.85
7.96
1.1
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
41
156
2.64
7.69
2.9
3.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
227
1532
1.50
7.65
1.4
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
43
168
2.57
7.65
1.7
2.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
140
844
1.67
7.64
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
37
135
2.75
7.52
1.2
1.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
168
1065
1.59
7.51
2.9
2.8
kpa
7.8
8.1
1.21
154
993
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
43
170
2.54
7.48
1.2
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
35
125
2.81
7.41
1.2
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
86
456
1.90
7.26
1.5
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
146
905
1.63
7.18
2.9
2.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2237
20284
1.16
7.01
3.9
3.5
ng/l
238.6
46.7
0.48
1586
13621
(3014111) Lactate [Moles/volume] in Serum or Plasma
564
4483
1.28
6.99
8.0
6.6
mmol/l
1.3
1.3
0.18
550
4329
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
66
324
2.05
6.95
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
54
246
2.21
6.89
2.4
2.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
327
4381
0.73
6.88
1.3
1.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
256
1808
1.43
6.88
3.8
3.9
mmol/l
1.4
1.4
0.37
249
1779
(3001964) Herpes simplex virus Ag [Presence] in Specimen
38
148
2.58
6.84
1.1
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
48
210
2.30
6.74
1.1
1.1
miu/ml
1360.3
1510.4
0.43
48
210
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
54
250
2.17
6.63
1.2
1.1
u/ml
12.8
30.5
—
8
24
(3013293) Extractable nuclear Ab [Presence] in Serum
26
85
3.07
6.45
1.7
1.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
245
1747
1.42
6.27
1.9
2.2
ug/l
930.3
646.0
0.24
226
1641
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
409
3162
1.31
6.27
4.1
3.5
kpa
5.1
5.2
2.02
383
2929
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
128
798
1.62
6.21
1.3
1.2
u/ml
5.3
3.1
0.57
53
244
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
56
272
2.07
6.12
2.4
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
56
272
2.07
6.12
2.4
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
56
272
2.07
6.12
2.4
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
56
272
2.07
6.12
2.4
1.8
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
34
133
2.56
6.10
1.1
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
524
4201
1.27
6.07
9.0
8.0
—
—
—
0
0
(3009343) pH of Capillary blood
402
3121
1.31
5.99
4.1
3.5
ph
7.4
7.4
0.70
64
398
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
20
59
3.40
5.85
1.2
2.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
296
2206
1.36
5.84
1.1
1.1
u/ml
34.0
1.8
—
6
33
(1616796) Gas panel - Central venous blood
167
1123
1.50
5.83
4.2
3.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3302
35002
0.88
5.71
2.9
3.1
u/l
50.8
47.3
1.15
3075
32466
(3014576) Chloride [Moles/volume] in Serum or Plasma
766
6451
1.21
5.65
7.7
6.7
mmol/l
103.9
104.4
2.20
744
6318
(3035880) pH of Pleural fluid
55
274
2.02
5.64
1.2
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
551
4490
1.25
5.57
2.7
2.8
ng/l
212.7
178.9
1.00
503
4084
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1185
10388
1.17
5.56
3.8
3.6
ng/l
440.9
435.7
0.01
956
7990
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
41
183
2.25
5.56
2.7
2.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
75
418
1.80
5.51
1.1
1.2
titre
96.1
184.3
1.63
28
82
(3036071) Salmonella sp Ab [Titer] in Serum
38
165
2.31
5.49
1.2
1.1
—
—
—
0
0
(3020891) Body temperature
274
2043
1.36
5.42
5.0
4.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
23
78
2.96
5.40
2.0
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
384
3013
1.29
5.31
4.1
3.4
mmol/l
2.3
1.8
1.81
283
2267
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
73
409
1.79
5.29
2.1
2.1
u/field
3.8
2.2
0.57
32
170
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
543
4446
1.24
5.26
2.3
2.3
ug/l
5.8
7.0
1.47
486
3872
(3005322) IgE [Units/volume] in Serum or Plasma
414
3304
1.27
5.02
1.3
1.3
u/ml
160.8
189.4
0.54
382
3040
(3043409) Potassium [Moles/volume] in Arterial blood
213
1545
1.39
5.02
4.0
4.2
mmol/l
3.9
3.9
0.01
197
1458
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
59
315
1.88
5.00
1.2
1.1
ratio
1.1
1.1
0.65
24
107
(21494890) Protein electrophoresis panel - 24 hour Urine
89
537
1.67
4.99
1.2
2.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
32
135
2.38
4.96
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
32
135
2.38
4.96
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
32
135
2.38
4.96
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
32
135
2.38
4.96
1.1
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
24
88
2.73
4.93
1.3
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
41
193
2.13
4.92
1.0
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
104
657
1.59
4.87
7.3
6.3
mg/l
11.9
11.7
0.20
95
614
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
29
118
2.46
4.86
1.2
1.2
ug/l
835.5
437.8
0.19
12
58
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
12
28
4.29
4.82
1.1
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
205
2783
0.73
4.77
1.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
49
250
1.97
4.76
1.3
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
119
780
1.54
4.76
1.3
1.2
u/ml
4.5
4.4
0.03
55
324
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
48
244
1.97
4.72
1.1
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
48
244
1.97
4.72
1.1
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
49
253
1.94
4.62
2.3
2.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
155
1080
1.45
4.61
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
155
1080
1.45
4.61
1.5
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
554
4617
1.22
4.56
3.4
3.7
kpa
5.7
5.8
1.54
534
4482
(3022217) INR in Platelet poor plasma by Coagulation assay
800
6903
1.18
4.52
19.6
23.9
inr
1.3
1.3
0.14
135
1023
(40767503) Oxygen content in Capillary blood by calculation
158
1110
1.43
4.50
3.0
2.5
%
15.0
16.1
3.07
86
554
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
39
187
2.09
4.50
1.1
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
33
148
2.24
4.49
1.1
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
24
93
2.59
4.46
1.9
2.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1303
11684
1.15
4.43
1.6
1.7
pmol/l
23784715.0
32853286.6
0.29
1131
9643
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
41
202
2.04
4.41
2.1
1.9
ug/l
50.3
54.9
0.32
41
197
(3001019) Free T4 and TSH panel - Serum or Plasma
202
2712
0.74
4.40
1.7
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
264
2025
1.32
4.38
1.9
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
355
2833
1.27
4.35
11.6
9.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1901
17484
1.12
4.32
3.3
3.2
u/l
33.6
35.1
0.29
1796
16572
(40768797) Stomach Pathology biopsy report
899
7866
1.17
4.27
1.2
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
548
4603
1.21
4.18
3.4
3.7
mmol/l
2.2
2.0
0.73
443
3764
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
73
1177
0.62
4.17
2.0
3.7
u/ml
81.5
29.1
0.43
68
1146
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3418
32514
1.11
4.16
2.9
2.8
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
36
173
2.09
4.15
2.2
2.0
%
25.9
29.1
0.71
31
163
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
509
4250
1.21
4.13
2.9
3.6
ng/l
75.2
87.5
3.48
446
3624
(4268621)
85
535
1.60
4.10
2.3
2.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
204
2704
0.75
4.10
2.0
2.2
nmol/l
12.5
12.2
0.20
185
2348
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1333
12038
1.14
4.04
1.2
1.3
u/ml
1.2
1.6
0.79
379
3231
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
645
5520
1.19
4.02
3.6
3.3
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
73
445
1.65
4.01
1.4
1.8
mg/l
4.2
4.1
0.06
68
427
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
27
117
2.31
4.00
1.5
1.4
%
38.5
24.9
1.03
22
99
(3003181) Sodium [Moles/volume] in Urine
136
952
1.44
4.00
1.4
1.4
mmol/l
69.2
62.0
1.19
108
768
(4010399)
475
3966
1.21
3.87
1.5
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
104
1525
0.68
3.84
1.3
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
5124
52445
0.88
3.83
4.0
4.7
mmol/l
5.8
5.9
10.65
4729
47798
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
481
5714
0.83
3.81
1.5
1.7
%
1.5
1.5
0.70
432
5012
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
20
77
2.60
3.80
1.2
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
25
537
0.46
3.79
1.0
1.1
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
35
173
2.03
3.78
2.4
2.1
%
5.3
9.5
2.49
28
160
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
280
2211
1.28
3.78
2.3
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
996
8860
1.15
3.77
1.5
1.5
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
16
55
2.91
3.73
1.6
1.1
mmol/l
5.1
7.0
—
10
27
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
51
288
1.78
3.71
1.2
1.1
u/l
71.9
79.5
0.61
39
224
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
125
876
1.44
3.68
1.1
1.2
u/ml
311.5
289.1
0.33
67
545
(3025941) Bacteria identified in Stool by Culture
364
2979
1.24
3.62
1.3
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
104
1506
0.69
3.62
1.5
1.7
mu/l
280.3
308.2
0.44
93
1357
(3016038) Potassium [Moles/volume] in Urine
59
351
1.69
3.59
1.2
1.2
mmol/l
31.4
34.2
0.44
44
303
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
33
163
2.03
3.59
1.4
1.5
ug/l
8.3
8.7
0.19
33
163
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
50
286
1.75
3.51
1.2
1.1
u/l
20.4
23.9
0.39
37
217
(3000060) B lymphocytes [#/volume] in Blood
26
119
2.19
3.43
2.0
2.1
e6/l
27.1
165.6
—
7
62
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
72
457
1.58
3.42
1.1
1.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1496
13731
1.12
3.41
3.8
3.8
%
90.0
91.7
1.87
1453
13388
(3012501) Base excess in Blood by calculation
158
1170
1.36
3.40
4.7
4.1
mmol/l
2.4
2.7
0.63
118
800
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
39
210
1.86
3.34
2.9
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
39
210
1.86
3.34
2.9
1.9
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
122
869
1.41
3.33
1.3
1.6
—
—
—
0
0
(3019977) pH of Arterial blood
50
291
1.72
3.32
2.8
3.2
ph
7.4
7.4
0.62
24
102
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
39
212
1.84
3.25
2.9
2.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
602
6906
0.86
3.17
4.0
4.6
%
35.1
32.7
5.19
459
4612
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
121
870
1.40
3.15
1.1
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
101
703
1.44
3.14
2.8
2.1
mg/l
23.0
22.8
0.01
28
181
(44806071)
17
67
2.54
3.12
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
4940
48204
1.11
3.10
27.9
14.9
%
38.7
39.4
5.77
3376
34182
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
19
80
2.38
3.05
1.9
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
628
7158
0.86
3.04
2.9
3.1
ug/l
0.8
0.8
0.12
424
4862
(3003458) Phosphate [Moles/volume] in Serum or Plasma
766
6797
1.14
3.02
4.3
5.6
mmol/l
1.0
1.0
0.13
723
6308
(4133840)
23
106
2.17
3.02
1.3
1.2
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
9
21
4.29
2.99
1.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
57
893
0.64
2.98
1.6
2.9
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
12
40
3.00
2.97
1.0
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
288
2355
1.23
2.95
3.2
3.9
mmol/l
24.6
24.3
0.92
254
2115
(3010421) pH of Blood
178
1379
1.30
2.87
4.7
4.0
ph
7.4
7.4
4.08
154
1149
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
74
494
1.50
2.87
1.1
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
36
624
0.57
2.86
1.1
1.1
u/ml
0.7
3.2
3.31
18
219
(3027456) Digoxin [Moles/volume] in Serum or Plasma
134
998
1.35
2.84
3.0
3.2
nmol/l
0.9
0.8
0.56
110
759
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
266
2166
1.24
2.84
5.9
5.3
%
1.8
1.6
0.91
249
2021
(3024354) Oxygen [Partial pressure] in Venous blood
442
3782
1.18
2.82
3.0
3.0
kpa
4.5
4.6
0.62
425
3658
(4034850)
223
1782
1.26
2.82
13.4
9.6
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
41
238
1.73
2.80
3.8
2.2
mmol/l
8.1
9.3
1.73
34
184
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
60
386
1.56
2.76
1.3
1.3
u/ml
0.6
1.0
0.49
37
179
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
45
270
1.67
2.74
1.0
1.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
897
8093
1.13
2.73
1.9
2.0
s
29.5
29.7
0.48
868
7845
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
889
9832
0.89
2.73
1.4
1.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
17
72
2.36
2.72
1.4
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
233
1881
1.25
2.71
2.7
2.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
324
3859
0.83
2.70
1.1
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
70
469
1.50
2.69
1.2
1.1
nmol/l
302.0
360.4
1.78
61
400
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
47
290
1.63
2.59
1.1
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
60
898
0.66
2.58
1.4
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
107
1446
0.74
2.58
1.8
1.8
iu/l
4.7
4.6
0.03
38
525
(3023323) Follitropin [Units/volume] in Serum or Plasma
187
2345
0.79
2.58
1.4
1.3
iu/l
33.7
33.0
0.11
162
2030
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
277
2292
1.22
2.57
2.6
2.6
%
0.7
0.6
1.85
256
2187
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
60
897
0.67
2.57
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
60
896
0.67
2.56
1.4
1.4
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
12
44
2.73
2.54
1.0
1.0
iu/ml
95.9
5.6
—
7
16
(3039443) Prostate specific Ag panel - Serum or Plasma
44
701
0.63
2.53
1.1
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
60
894
0.67
2.53
1.4
1.4
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
13
50
2.60
2.53
3.8
2.6
u/field
1.1
0.6
0.76
13
50
(3041918) Cholesterol [Moles/volume] in Pleural fluid
21
101
2.08
2.52
1.5
1.2
mmol/l
3.3
1.8
1.62
12
63
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
14
57
2.46
2.44
1.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
16
336
0.47
2.40
1.1
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
50
320
1.57
2.40
1.5
1.6
u/l
5.2
6.5
1.10
42
274
(36660697) Celiac disease serology panel - Serum
498
4367
1.15
2.37
1.1
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
67
962
0.69
2.35
1.4
1.5
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
9
28
3.22
2.30
1.0
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
21
106
1.98
2.25
1.2
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
9
29
3.11
2.22
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
9
29
3.11
2.22
1.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
626
5605
1.13
2.19
4.2
4.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
45
288
1.57
2.18
1.2
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
20
101
1.98
2.15
1.3
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
31
182
1.71
2.10
1.3
1.5
%
45.7
64.5
1.75
24
149
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
12
49
2.45
2.10
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
107
812
1.32
2.10
1.4
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
38
236
1.61
2.10
1.1
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
123
954
1.30
2.06
1.3
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
78
565
1.39
2.06
3.1
5.0
mmol/l
7.0
7.4
0.31
64
470
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1406
13167
1.09
2.05
2.4
2.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
16
76
2.11
2.02
1.7
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
345
2985
1.16
2.01
2.5
2.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
293
2503
1.18
2.00
1.2
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
76
552
1.38
1.99
4.1
3.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
719
6534
1.11
1.97
1.9
2.2
ug/g
148.4
132.2
0.65
576
5084
(1001926) Buprenorphine [Presence] in Urine by Screen method
76
1031
0.73
1.96
1.3
2.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
255
2158
1.19
1.95
6.0
5.4
%
0.9
0.9
0.64
239
2015
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1805
17108
1.08
1.93
2.4
2.5
u/l
62.5
57.5
1.53
1669
15731
(3023183) Ammonium ion [Moles/volume] in Plasma
78
1051
0.74
1.93
2.5
2.9
umol/l
31.5
35.0
0.83
68
892
(3038177) Helicobacter pylori Ab [Presence] in Serum
65
900
0.72
1.91
1.2
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
18
92
1.96
1.89
2.2
2.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
121
950
1.28
1.88
1.1
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
24
136
1.77
1.86
2.1
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
39
590
0.66
1.86
1.5
2.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
81
602
1.35
1.86
1.2
1.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
9
34
2.65
1.86
1.0
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
298
3449
0.86
1.86
2.9
3.8
u/ml
64.3
57.0
0.15
285
3314
(3020779) Urea [Moles/volume] in Serum or Plasma
506
4527
1.13
1.83
5.7
7.2
mmol/l
9.6
9.7
0.13
481
4316
(3047352) Trisomy 18 risk [Likelihood] in Fetus
53
752
0.70
1.82
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
55
774
0.71
1.80
1.5
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
100
771
1.30
1.80
1.7
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
53
750
0.70
1.79
1.4
1.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
17
87
1.96
1.79
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
167
1370
1.22
1.79
1.2
1.2
—
—
—
0
0
(4146454)
40
595
0.67
1.77
3.4
2.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
680
6201
1.11
1.77
1.2
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
32
200
1.60
1.76
1.1
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
108
844
1.28
1.76
1.2
1.4
u/ml
138.5
118.6
0.26
28
172
(3039000) Anion gap in Blood
149
1210
1.24
1.76
7.6
7.3
mmol/l
11.5
11.2
0.41
136
1077
(3024891) Influenza virus A+B Ag [Presence] in Specimen
159
1301
1.23
1.75
1.2
1.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
149
1211
1.24
1.75
7.6
7.3
mmol/l
104.9
105.2
0.28
136
1078
(3023430) Cat dander IgE Ab [Units/volume] in Serum
38
569
0.67
1.74
1.1
1.1
u/ml
0.6
3.5
5.11
17
206
(40768800) Prostate Pathology biopsy report
58
803
0.72
1.74
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
107
837
1.28
1.74
1.8
1.7
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
54
381
1.42
1.71
3.1
2.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
187
1563
1.20
1.68
1.2
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
199
1673
1.20
1.68
6.8
6.3
mmol/l
1.5
1.3
1.32
176
1466
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
920
9900
0.92
1.67
3.8
4.3
%
21.0
21.8
1.09
447
4898
(3001893) Eosinophils/100 leukocytes in Pleural fluid
25
149
1.68
1.66
1.2
1.5
%
2.4
3.0
0.17
20
127
(3015183) Erythrocyte sedimentation rate
38
252
1.51
1.65
1.3
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
60
435
1.38
1.64
1.1
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1161
12355
0.93
1.60
4.3
5.0
ug/l
2.4
3.6
1.95
1046
11051
(3044889) 12 lead EKG panel
3899
38070
1.06
1.60
3.8
3.7
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
25
151
1.66
1.59
1.6
1.8
u/l
88.3
42.5
0.30
20
141
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
33
214
1.54
1.59
1.5
1.8
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
26
412
0.63
1.58
1.1
1.5
g/l
0.8
0.9
0.94
26
412
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
6
20
3.00
1.58
1.2
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
43
296
1.46
1.57
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
177
2102
0.84
1.55
1.5
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
10
44
2.27
1.53
1.4
1.2
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
5
15
3.34
1.52
1.0
1.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
27
2.59
1.51
1.1
1.1
—
—
—
0
0
(4015189)
24
146
1.65
1.50
2.2
2.3
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
15
79
1.90
1.49
1.3
1.5
%
13.9
10.7
—
9
42
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
78
1006
0.77
1.48
2.3
1.9
nmol/l
1.0
0.8
1.55
68
845
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
59
436
1.36
1.47
1.3
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
40
276
1.45
1.46
1.1
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
4567
44864
1.06
1.46
35.0
17.9
g/l
329.5
331.8
55.42
4542
44558
(3002619) Bacteria identified in Specimen by Culture
18
102
1.77
1.44
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
185
1571
1.18
1.44
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
201
1720
1.17
1.43
3.1
2.9
u/ml
0.4
0.3
0.38
122
969
(3050129) First trimester maternal screen panel - Serum or Plasma
85
1078
0.79
1.43
1.4
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
35
508
0.69
1.42
1.0
1.1
u/ml
0.1
0.3
1.41
11
108
(3022313) Gas panel - Capillary blood
261
2280
1.15
1.42
4.6
3.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
76
975
0.78
1.40
1.4
1.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
323
3633
0.88
1.40
2.5
3.3
pmol/l
4.2
4.4
3.13
284
3219
(3042010) Triglyceride [Moles/volume] in Pleural fluid
15
81
1.85
1.39
1.6
1.3
mmol/l
0.4
1.7
—
9
53
(3020356) Listeria sp identified in Specimen by Organism specific culture
7
29
2.42
1.39
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
182
1549
1.18
1.39
1.3
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
51
372
1.37
1.39
1.5
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
204
1753
1.17
1.38
1.5
1.7
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
14
74
1.89
1.38
1.4
1.3
u/l
27.4
477.5
—
8
54
(3010726) Horse dander IgE Ab [Units/volume] in Serum
53
712
0.74
1.37
1.1
1.1
u/ml
0.1
2.0
4.13
17
158
(3000492) Spirometry study
548
5016
1.10
1.37
1.5
1.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
56
416
1.35
1.37
1.2
1.3
mmol/l
14.8
12.0
0.76
15
101
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
14
249
0.56
1.36
1.1
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
18
104
1.73
1.36
1.3
1.5
ng/l
121.4
115.3
0.06
18
104
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
168
1424
1.18
1.35
1.3
1.3
miu/ml
187.0
222.6
0.63
61
681
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
25
159
1.57
1.34
1.1
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
40
0.00
1.32
0.0
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
46
333
1.38
1.32
2.1
2.1
ug/l
2.4
2.4
0.04
39
283
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
552
6006
0.91
1.31
3.2
4.0
ug/l
24.2
25.5
0.05
452
4815
(3026470) Cobalt [Mass/volume] in Blood
47
342
1.38
1.31
1.9
2.0
ug/l
4.4
3.0
1.15
41
301
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
6
24
2.50
1.30
1.3
5.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
150
1264
1.19
1.30
1.3
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
127
1054
1.21
1.29
2.0
2.8
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
273
2411
1.14
1.29
3.7
3.3
mmol/l
25.4
25.3
0.25
265
2337
(3004119) Hemoglobin [Mass/volume] in Venous blood
342
3064
1.12
1.29
3.3
3.2
g/l
123.4
128.6
4.40
334
2981
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
18
106
1.70
1.29
1.0
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
34
2.35
1.29
1.1
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
5
18
2.78
1.28
1.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
14
241
0.58
1.24
2.1
2.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
111
1340
0.83
1.22
1.4
2.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
36
254
1.42
1.21
1.2
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1803
17333
1.06
1.20
2.5
2.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
24
156
1.54
1.19
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
30
205
1.47
1.19
1.0
1.1
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
6
26
2.31
1.18
1.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
329
3652
0.90
1.18
1.5
1.6
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
38
2.11
1.18
1.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
12
64
1.88
1.18
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
124
1040
1.20
1.16
2.2
2.9
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
55
714
0.77
1.16
1.3
1.3
mmol/l
7.2
7.4
0.17
36
534
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
142
1666
0.85
1.16
1.5
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
59
757
0.78
1.14
1.0
1.1
u/ml
0.6
1.1
0.97
23
303
(3003888) Timothy IgE Ab [Units/volume] in Serum
62
790
0.78
1.14
1.0
1.1
u/ml
3.9
4.6
0.16
33
378
(3000764) Benzodiazepines [Presence] in Urine
111
1328
0.83
1.13
1.4
2.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
16
259
0.62
1.13
2.1
2.1
ug/min
99.0
154.7
—
5
58
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
71
889
0.80
1.13
1.1
1.1
u/ml
0.8
1.2
0.28
33
331
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
32
225
1.42
1.11
1.8
2.1
umol/l
138.6
142.0
0.02
25
125
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
159
1.51
1.11
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
112
1335
0.84
1.11
1.4
2.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
176
2022
0.87
1.10
3.0
3.4
u/ml
380.3
2844.3
1.04
147
1722
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
7
31
2.26
1.10
1.0
2.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
35
479
0.73
1.08
1.1
1.5
ug/l
4.0
3.9
0.05
29
400
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
252
2247
1.13
1.07
4.4
3.9
%
49.3
48.2
0.32
247
2220
(4281824)
55
704
0.78
1.06
1.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
111
1316
0.84
1.05
1.5
1.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
72
579
1.25
1.04
1.2
1.2
—
—
—
0
0
(4035726)
475
5136
0.92
1.03
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
103
1225
0.84
1.01
1.4
2.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
15
91
1.65
1.00
1.2
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
9
49
1.84
0.98
1.2
1.7
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
14
224
0.62
0.97
1.5
1.3
umol/l
2.3
4.1
1.79
14
207
(40758358) Immune stain study
0
30
0.00
0.97
0.0
1.0
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.0
—
1.1
—
0
13
(3000570) Elastase.pancreatic [Mass/mass] in Stool
148
1701
0.87
0.97
1.4
1.4
ug/g
287.8
278.2
0.28
96
982
(40762814) Titanium [Mass/volume] in Blood
15
92
1.63
0.97
1.9
2.2
ug/l
3.4
4.3
—
6
36
(3008116) Ketones [Moles/volume] in Urine by Test strip
16
100
1.60
0.96
1.6
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
35
258
1.36
0.96
1.1
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
94
1119
0.84
0.95
1.3
1.3
u/l
14.9
13.0
0.57
79
919
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
32
0.00
0.95
0.0
8.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
97
816
1.19
0.93
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
179
2022
0.88
0.92
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
5368
53201
1.06
0.92
4.3
4.5
mmol/l
4.7
4.7
7.89
5029
49145
(3027974) Hepatitis B virus e Ag [Presence] in Serum
6
28
2.14
0.91
1.5
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1607
16642
0.95
0.91
3.8
4.0
mg/mmol
8.9
8.7
0.07
1049
10192
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
227
2526
0.89
0.91
1.8
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
46
587
0.78
0.90
1.0
1.1
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
16
102
1.57
0.90
1.3
1.1
%
74.0
83.8
—
7
25
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
59
730
0.81
0.89
1.1
1.1
u/ml
1.7
3.1
1.47
20
314
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
47
367
1.28
0.89
1.1
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
5
101
0.49
0.89
1.0
1.1
u/ml
83.1
50.5
—
5
96
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
20
135
1.48
0.89
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
20
135
1.48
0.89
2.1
1.8
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
59
729
0.81
0.88
1.7
1.4
nmol/l
0.3
0.4
1.44
45
548
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
220
1976
1.12
0.87
5.0
3.7
mmol/l
25.5
24.9
2.60
204
1813
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
27
369
0.73
0.87
1.0
1.0
ng/l
358.8
338.5
0.16
22
249
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
177
1990
0.89
0.86
1.7
1.6
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
8
45
1.78
0.84
2.5
2.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
10
57
1.76
0.83
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
23
320
0.72
0.83
1.3
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
190
2120
0.89
0.82
1.5
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
5052
50028
1.05
0.82
4.8
5.0
mu/l
2.0
2.1
0.93
4661
45842
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
17
113
1.51
0.82
1.2
1.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
55
445
1.24
0.80
1.3
1.3
nmol/l
1.8
1.5
1.08
49
406
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
5328
52839
1.05
0.80
4.2
4.4
mmol/l
1.6
1.5
36.07
4985
48513
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
89
757
1.18
0.79
1.1
1.1
—
—
—
0
0
(44806420)
9
147
0.61
0.78
2.4
2.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
8
48
1.67
0.78
1.3
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
5463
54219
1.06
0.78
4.7
5.0
mmol/l
2.7
2.8
22.66
5099
49818
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
60
492
1.22
0.78
2.3
2.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
25
182
1.38
0.77
1.4
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
62
511
1.22
0.77
2.3
2.9
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
53
1.70
0.75
1.1
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
18
124
1.45
0.75
1.1
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
12
75
1.60
0.74
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
19
267
0.71
0.74
1.0
1.3
nmol/l
157.5
135.2
1.49
19
267
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
131
1480
0.88
0.72
1.4
1.4
pmol/l
286.9
166.9
0.56
126
1447
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
10
60
1.67
0.72
1.0
1.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
19
134
1.42
0.71
2.4
1.7
mmol/l
1.4
0.8
0.26
19
126
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
4310
42590
1.04
0.70
4.1
4.2
pmol/l
15.1
14.8
15.35
3956
38766
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
58
1.55
0.69
1.1
1.4
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
36
283
1.27
0.69
1.3
1.4
nmol/l
1.5
1.3
0.43
25
222
(3004716) Salmonella sp identified in Stool by Organism specific culture
279
2575
1.09
0.69
1.4
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
21
152
1.38
0.69
2.4
3.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
21
152
1.38
0.69
2.4
3.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
45
364
1.24
0.68
1.1
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
48
584
0.82
0.67
1.6
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4927
49702
0.96
0.67
5.2
5.8
mmol/mol
38.3
39.7
19.86
4628
45865
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
29
374
0.77
0.67
1.0
1.0
ng/l
46.3
45.7
0.03
22
247
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
19
136
1.40
0.66
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
163
1469
1.11
0.66
1.3
1.4
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
25
188
1.33
0.66
1.1
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
7
44
1.59
0.65
1.1
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
153
1378
1.11
0.64
1.1
1.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
29
371
0.78
0.64
1.0
1.0
ng/l
823.0
702.1
0.76
22
242
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
29
1.72
0.64
1.6
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
44
359
1.23
0.63
1.6
1.7
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
79
1.52
0.62
1.0
1.1
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
15
104
1.44
0.62
1.3
1.3
%
103.7
110.8
0.27
15
98
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
56
470
1.19
0.62
1.2
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
21
279
0.75
0.61
1.1
1.1
u/l
1.2
1.1
—
8
129
(40761539) Cells [Type] in Urine sediment by Light microscopy
18
130
1.39
0.61
1.3
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
138
0.65
0.60
7.7
5.1
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.5
—
1.6
—
0
20
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
22
165
1.33
0.60
1.2
1.1
%
89.0
90.2
—
9
78
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
34
421
0.81
0.58
1.0
1.0
mg/l
298.7
290.2
0.21
29
375
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
134
1486
0.90
0.58
1.0
1.1
u/ml
3.2
6.5
0.72
11
158
(3024932) HLA-DR beta [Type]
10
150
0.67
0.58
1.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1624
16654
0.97
0.58
3.1
3.2
mmol/l
7.0
7.2
0.80
1398
13941
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
409
3863
1.06
0.57
1.8
1.8
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
28
220
1.27
0.56
1.9
2.2
umol/l
46.5
54.6
—
8
177
(3025468) Yersinia sp identified in Specimen by Organism specific culture
82
718
1.14
0.56
1.3
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
128
1153
1.11
0.56
1.2
1.3
e6/l
23.6
24.3
0.02
96
883
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
15
206
0.73
0.55
1.3
1.8
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
128
1154
1.11
0.55
1.2
1.2
mmol/l
3.8
3.8
0.05
119
1080
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
82
719
1.14
0.55
1.3
1.4
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
22
168
1.31
0.54
1.5
2.1
%
223.4
176.9
0.62
17
156
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
134
1479
0.90
0.54
1.7
2.1
u/l
7819.2
4998.7
0.32
53
594
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
128
1156
1.11
0.54
1.3
1.4
e6/l
2290.5
1286.4
0.24
103
933
(3044007) Cell count panel - Peritoneal fluid
20
151
1.33
0.53
1.6
2.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
79
693
1.14
0.53
1.2
1.3
pmol/l
291.9
338.5
0.42
62
530
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
164
1502
1.09
0.52
2.3
2.4
g/l
4.1
3.6
2.88
158
1417
(3005988) Vibrio sp identified in Specimen by Organism specific culture
82
722
1.14
0.52
1.3
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
29
360
0.80
0.52
1.1
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
82
723
1.14
0.52
1.3
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
9
64
1.41
0.51
1.0
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
42
351
1.20
0.51
1.3
1.4
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
27
336
0.80
0.50
1.2
1.1
nmol/l
0.4
11.3
—
5
73
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
11
75
1.47
0.50
1.1
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
9
65
1.39
0.50
1.1
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
43
361
1.19
0.50
1.3
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
24
302
0.79
0.49
1.2
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
64
557
1.15
0.49
1.2
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
18
136
1.32
0.49
1.1
1.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1547
15828
0.97
0.48
3.1
3.2
mg/l
586.6
406.5
0.63
1027
9644
(3023511) Choriogonadotropin [Units/volume] in Urine
66
753
0.88
0.48
1.5
1.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
21
163
1.29
0.48
1.2
1.2
%
98.6
90.5
—
8
80
(3051387) C reactive protein [Mass/volume] in Capillary blood
127
1156
1.10
0.48
4.1
3.4
mg/l
30.7
26.3
0.71
86
705
(44816559) Phosphatidylethanol [Mass/volume] in Blood
79
890
0.89
0.48
1.4
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
128
1.33
0.47
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
82
729
1.13
0.47
1.3
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
18
137
1.31
0.47
1.1
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
10
68
1.47
0.47
1.1
2.1
—
—
—
0
0
(3024471) HLA-A [Type]
11
154
0.71
0.47
1.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
53
457
1.16
0.46
1.1
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
59
676
0.87
0.46
1.3
1.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
24
191
1.26
0.46
1.4
1.6
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
16
210
0.76
0.46
1.1
1.1
ng/l
72.2
427.8
—
5
49
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
46
536
0.86
0.45
1.7
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
25
309
0.81
0.45
1.1
1.1
—
—
—
0
0
(4024509)
66
581
1.14
0.45
1.6
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
116
1056
1.10
0.45
1.2
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
70
790
0.88
0.44
1.6
1.5
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
83
742
1.12
0.44
1.2
1.5
mu/l
55.9
57.0
0.02
74
657
(43055442) Apixaban [Mass/volume] in Serum or Plasma
10
69
1.45
0.44
1.7
1.5
ug/l
151.2
108.0
—
10
58
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
16
121
1.32
0.44
1.1
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
58
507
1.15
0.44
2.0
1.9
umol/l
7.6
8.0
0.07
42
357
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
18
139
1.30
0.43
1.1
1.1
pmol/l
292.2
309.6
—
10
102
(3020191) Ethanol [Moles/volume] in Serum or Plasma
31
372
0.83
0.43
1.1
1.5
promille
1.6
1.2
1.05
25
283
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
69
777
0.89
0.43
1.4
1.3
u/l
34.7
31.2
0.28
49
631
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
28
339
0.83
0.42
1.1
1.1
iu/ml
16.2
10.5
0.25
11
91
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
19
240
0.79
0.42
1.1
1.4
pmol/l
63.8
179.8
—
8
79
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
88
793
1.11
0.42
1.2
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
32
267
1.20
0.42
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
32
267
1.20
0.42
1.3
1.4
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
593.9
—
0
15
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.2
—
45.2
—
0
10
(3049242) von Willebrand panel - Platelet poor plasma
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
8
59
1.36
0.41
1.0
1.2
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
17
0.00
0.40
0.0
5.6
—
387.9
—
0
17
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
2.4
—
0
17
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
199
1865
1.07
0.40
1.5
1.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
61
1.31
0.39
1.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
101
0.69
0.39
7.3
8.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
103
0.68
0.39
1.4
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
82
740
1.11
0.39
1.3
1.4
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
453
4353
1.04
0.38
1.9
1.9
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
59
523
1.13
0.38
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
412
4294
0.96
0.38
1.4
1.4
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
25
206
1.21
0.37
2.9
5.0
mg/l
444.8
1026.4
0.24
17
151
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
64
571
1.12
0.37
1.2
1.1
%
96.6
95.5
0.11
59
536
(3003694) ABO and Rh group [Type] in Blood
1473
14446
1.03
0.37
1.4
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
115
0.70
0.37
1.6
2.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
60
534
1.12
0.37
1.3
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
169
0.77
0.36
1.6
2.1
—
—
—
0
0
(3036603) Volume of Urine
43
374
1.15
0.36
1.2
1.5
ml
1839.3
1874.4
—
8
89
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
30
353
0.85
0.36
1.5
2.0
nmol/l
15.8
17.4
0.73
23
331
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
712
7328
0.97
0.35
1.3
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
125
1346
0.93
0.35
4.3
4.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
131
1218
1.08
0.34
2.3
2.4
ug/min
81.0
84.4
0.05
73
719
(3004446) Plasmodium sp identified in Blood by Light microscopy
6
44
1.36
0.34
2.2
2.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
6
45
1.33
0.33
1.3
6.7
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
16
127
1.26
0.33
1.1
1.3
mu/l
25.9
64.1
—
10
100
(3025549) Creatine [Moles/time] in 24 hour Urine
6
46
1.30
0.33
1.0
1.4
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
17
209
0.81
0.32
1.2
1.5
iu/ml
—
1182955.0
—
0
10
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
52
1.35
0.31
1.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
17
138
1.23
0.30
1.9
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
669
6870
0.97
0.30
8.0
6.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
34
296
1.15
0.30
1.1
1.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
20
238
0.84
0.28
1.1
1.0
%
83.6
94.6
1.40
14
180
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
8
62
1.29
0.28
1.1
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
121
0.74
0.27
1.2
1.2
—
—
—
0
0
(4198724)
12
150
0.80
0.27
1.4
1.7
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
58
636
0.91
0.27
1.2
1.3
—
33.7
—
0
6
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
49
542
0.90
0.26
3.8
4.9
u/ml
40.1
85.9
1.23
15
147
(3034092) Cytoplasmic Ig cells/100 cells in Blood
8
67
1.19
0.26
28.4
10.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
58
529
1.10
0.26
1.0
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
45
405
1.11
0.26
1.4
1.5
u/ml
23.9
20.3
—
7
86
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
74
0.68
0.26
2.4
5.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
30
263
1.14
0.25
1.7
1.5
mmol/l
8.1
8.0
0.01
18
158
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
18
213
0.84
0.25
1.4
2.9
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
9
76
1.18
0.24
1.1
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
9
76
1.18
0.24
1.2
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
16
133
1.20
0.24
1.1
1.1
u/ml
0.1
1.5
—
7
62
(40758292) HTLV I+II Ab panel - Serum
6
82
0.73
0.24
1.3
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
83
0.72
0.24
1.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
46
417
1.10
0.24
1.2
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
5118
50994
1.02
0.23
3.9
4.0
mmol/l
1.2
1.3
23.55
4768
46436
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
91
0.77
0.22
1.9
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
18
153
1.18
0.22
1.1
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
10
124
0.81
0.21
1.2
1.3
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
19
163
1.17
0.21
1.4
2.1
e6/l
795.1
19173.6
—
8
93
(3017509) Phencyclidine [Presence] in Urine
5
42
1.19
0.21
1.0
1.3
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(4038314)
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
1.3
—
0
13
(3034614) HLA Ag [Interpretation]
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
30
268
1.12
0.20
2.7
2.8
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
80
752
1.06
0.19
1.2
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
122
0.82
0.19
1.8
2.3
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
21
184
1.14
0.19
1.6
2.4
e6/l
463.3
783.1
0.68
13
133
(3022689) Creatine [Moles/volume] in Urine
13
154
0.84
0.19
2.3
1.4
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
34
374
0.91
0.18
1.1
1.1
mg/l
40.4
40.1
0.02
28
313
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
81
764
1.06
0.18
1.2
1.1
%
126.8
118.8
1.28
73
684
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
33
363
0.91
0.18
1.1
1.1
mg/l
227.9
263.8
0.80
27
317
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
137
1314
1.04
0.17
1.2
1.3
mg/l
932.5
522.7
0.65
129
1238
(3029396) Erythrocyte agglutination [Presence] in Blood
11
91
1.21
0.17
3.3
3.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
11
91
1.21
0.17
1.1
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
20
226
0.88
0.17
1.7
1.5
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
143
1486
0.96
0.16
2.2
2.3
%
209.7
193.2
1.13
136
1413
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
65
612
1.06
0.16
1.4
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
18
158
1.14
0.16
1.8
2.0
—
—
—
0
0
(4027681)
26
287
0.91
0.15
1.2
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
126
1311
0.96
0.15
2.4
2.9
mg/l
1.6
1.5
0.62
112
1200
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
77
0.78
0.15
6.0
7.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
523
5138
1.02
0.15
2.2
2.2
g/l
0.2
0.2
1.25
475
4802
(3003740) Influenza virus B Ag [Presence] in Specimen
76
721
1.05
0.15
1.1
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
33
359
0.92
0.15
1.2
1.3
—
411.4
—
0
29
(40768441) Liver Pathology biopsy report
45
419
1.07
0.15
1.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
11
93
1.18
0.14
1.0
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
7
90
0.78
0.14
1.3
2.7
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
156
1610
0.97
0.13
1.9
2.0
%
93.0
92.3
0.11
138
1497
(3012565) Volume of 24 hour Urine
25
274
0.91
0.13
1.8
2.4
ml
2112.4
1888.7
0.40
17
247
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
371
3781
0.98
0.13
1.2
1.2
iu/ml
124.1
147.9
0.64
151
1419
(4306422)
83
795
1.04
0.12
1.3
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
84
805
1.04
0.12
1.3
1.3
nmol/l
0.7
2.6
0.69
79
770
(3008295) Osmolality of Serum or Plasma
59
560
1.05
0.12
1.4
1.4
mosm/kgh2o
273.2
277.2
0.82
44
435
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
74
708
1.05
0.12
1.1
1.1
g/l
1.5
1.5
0.08
65
637
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
15
133
1.13
0.12
1.1
1.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
114
1178
0.97
0.11
2.6
3.4
u/ml
271.4
612.1
0.69
99
1071
(3012095) Magnesium [Moles/volume] in Serum or Plasma
882
8732
1.01
0.11
3.1
3.2
mmol/l
0.8
0.8
1.54
806
8128
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
42
445
0.94
0.11
1.2
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
627
6196
1.01
0.11
2.2
2.7
umol/l
6.4
8.1
2.07
535
5364
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
115
0.87
0.10
6.9
7.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
35
372
0.94
0.10
5.1
6.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
29
271
1.07
0.09
7.6
3.3
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
22
238
0.92
0.09
1.0
1.0
u/ml
0.3
2.3
—
5
38
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
22
203
1.08
0.09
1.2
1.6
—
—
—
0
0
(3013512) EKG study
1589
15977
0.99
0.09
3.8
3.9
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
6
55
1.09
0.08
1.2
1.3
—
640.5
—
0
9
(3016750) Collection duration of Urine
31
292
1.06
0.08
1.8
2.2
min
504.7
492.2
0.22
18
215
(3033705) Calcium.ionized [Moles/volume] in Venous blood
59
613
0.96
0.08
2.5
2.3
—
—
—
0
0
(4094501)
143
1462
0.98
0.08
1.1
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
64
0.78
0.08
1.2
1.0
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
5
65
0.77
0.08
1.0
1.0
u/ml
0.0
1.6
—
5
45
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
14
154
0.91
0.08
1.1
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
37
389
0.95
0.08
2.1
2.1
mmol/l
7.5
6.6
0.74
27
251
(3026692) Albumin [Mass/volume] in Peritoneal fluid
14
127
1.10
0.07
1.0
1.5
g/l
13.3
12.9
—
6
99
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
71
0.84
0.07
1.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
75
1.07
0.07
1.1
1.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
35
333
1.05
0.07
1.1
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
147
1441
1.02
0.07
1.2
1.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
9
88
1.02
0.07
1.0
1.0
mg/g
5.3
8.3
—
9
82
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
14
128
1.09
0.06
1.3
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
9
105
0.86
0.06
1.3
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
74
720
1.03
0.06
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
49
473
1.04
0.06
1.1
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
75
770
0.97
0.06
1.1
1.1
iu/ml
101.7
13703.3
0.53
18
171
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
35
335
1.05
0.06
1.1
1.0
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
26
274
0.95
0.06
1.0
1.0
u/ml
0.5
2.7
—
10
80
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
517
5130
1.01
0.06
2.3
2.4
u/l
37.2
46.5
0.46
439
4363
(4211845)
31
296
1.05
0.05
7.2
3.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
24
228
1.05
0.05
1.1
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
25
238
1.05
0.05
8.1
11.7
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
25
262
0.95
0.04
2.8
2.6
—
31.4
—
0
5
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
20
210
0.95
0.03
1.3
1.5
umol/l
30.5
29.9
0.15
20
203
(3014599) Egg white IgE Ab [Units/volume] in Serum
26
270
0.96
0.03
1.0
1.0
u/ml
0.4
0.7
0.57
11
62
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
92
1.09
0.03
1.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
66
649
1.02
0.02
5.7
2.8
%
13.6
13.2
2.21
66
641
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
27
261
1.03
0.02
1.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
27
279
0.97
0.02
1.3
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
15
158
0.95
0.02
1.7
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
40
407
0.98
0.01
2.0
2.0
%
11.0
11.1
0.02
40
407
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
14
146
0.96
0.00
1.1
1.1
—
—
—
0
0
(44813793)
38
374
1.02
0.00
1.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2306
23053
1.00
0.00
2.1
2.1
—
—
—
0
0
(3036489) Thrombin time
195
1956
1.00
0.00
1.9
1.9
s
21.2
21.5
0.26
170
1701
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
13
135
0.96
0.00
1.2
2.1
ug/l
7.1
2.4
—
5
72
(3006922) Hepatitis E virus Ab [Presence] in Serum
37
368
1.01
0.00
1.1
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
16
165
0.97
0.00
1.5
2.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
30
305
0.98
0.00
1.0
1.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
40
405
0.99
0.00
1.8
2.2
ml
757.0
625.6
0.78
23
268
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
21
206
1.02
0.00
1.1
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
31
314
0.99
0.00
5.6
3.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
35
346
1.01
0.00
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
70
696
1.01
0.00
1.8
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1474
14735
1.00
0.00
1.6
1.6
mmol/l
1.3
1.4
4.57
1260
12320
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
159
1586
1.00
0.00
1.7
1.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
73
733
1.00
0.00
1.3
1.3
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
6
61
0.98
0.00
2.3
6.4
ug/min
70.8
53.0
—
6
46
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
7
70
1.00
0.00
1.4
1.2
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
5
54
0.93
0.00
1.0
1.2
mg/l
11.0
9.5
—
5
49
(3022670) pH of Venous cord blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
59
1.02
0.00
1.3
2.1
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
1.2
—
0
9
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
5
0.00
0.00
0.0
1.2
—
65.4
—
0
5
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
5
0.00
0.00
0.0
2.0
—
6.4
—
0
5
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
68
0.88
0.00
5.8
12.1
mmol/l
5.8
5.4
—
6
68
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
91.3
—
0
6
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008343) Lysozyme [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
0.5
—
0
5
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
8
89
0.90
0.00
1.3
1.5
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
7
70
1.00
0.00
1.4
1.2
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
25.8
—
0
5
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
9
89
1.01
0.00
4.7
6.7
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
7
70
1.00
0.00
1.4
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
9
99
0.91
0.00
3.9
2.9
u/l
9655.0
1787.6
—
9
94
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
6
67
0.90
0.00
5.8
3.7
umol/l
32.7
42.3
—
6
56
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
54
0.93
0.00
1.0
1.2
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
7
70
1.00
0.00
1.1
3.0
—
31.4
—
0
11
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
1432.9
—
0
7
(3000034) Microalbumin [Mass/volume] in Urine
51
510
1.00
0.00
3.6
2.9
mg/l
51.5
27.5
0.61
46
368
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
9
0.00
0.00
0.0
1.3
—
2858.5
—
0
9
(3028714) Urate [Moles/time] in 24 hour Urine
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
8
0.00
-0.00
0.0
1.1
—
118.3
—
0
8
Mortality – FinRegistry
↥Association
Association between endpoint RHEUMA_SEROPOS_STRICT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| RHEUMA_SEROPOS_STRICT | 1.267 [1.16, 1.38] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.474 |
During the follow-up period (1.1.1998 — 31.12.2019), 2802 out of 18091 females with RHEUMA_SEROPOS_STRICT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| RHEUMA_SEROPOS_STRICT | 1.387 [1.26, 1.52] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 2121 out of 8553 males with RHEUMA_SEROPOS_STRICT died.
Mortality risk
Mortality risk for people of age
years, who have RHEUMA_SEROPOS_STRICT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.099% | 0.247% |
| 5 | 0.74% | 1.452% |
| 10 | 2.046% | 3.767% |
| 15 | 3.95% | 7.307% |
| 20 | 6.912% | 12.196% |
Relationships between endpoints
↥Index endpoint: RHEUMA_SEROPOS_STRICT – Seropositive rheumatoid arthritis, strict definition
GWS hits: 23
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data